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1. What is this thesis about? 
 
 
This thesis has two main focuses 
 
x To understand the effects of neonatal resuscitation with 100% oxygen on lung 
hyaluronan (HA). HA is an abundant extracellular matrix component with important 
biological activities. It is a dynamic molecule that can differently promote or inhibit 
lung pathology on the basis of its molecular weight and accessibility to various HA-
binding proteins. While high molecular weight HA functions to maintain lung 
structural integrity, low molecular weight HA activates innate inflammatory 
responses via various signalling pathways. We wanted to study the effects of 100% 
oxygen resuscitation on HA degradation in the lungs of asphyxiated newborn pigs, 
and compare the results with other markers of inflammation. Furthermore, we wanted 
to investigate whether treatment with the antioxidant N-acetylcysteine could decrease 
fragmentation of HA in the pig lung. We also planned an in vitro stimulation of 
macrophages with HA. 
 
x The other main focus of this thesis is to clarify the biological relevance and activities 
of HA, its receptors/hyaluronan-binding proteins Toll-like receptors 2 and 4, Cluster 
of differentiation 44 (CD44) and Hyaluronan-mediated motility receptor (RHAMM) 
in human umbilical cord blood. Characterization of the distinct inflammatory 
responses of leukocytes at birth is central to understanding neonatal immunity. Toll-
like receptors (TLRs) are key components of the innate immune system as they detect 
invading pathogens. TLR4 is known to respond to lipopolysaccharide, which is the 
major component of the outer membrane of Gram-negative bacteria, and is also 
involved in recognition of respiratory syncytial virus fusion proteins.  
We intended to study the effects of HA on surface expression of TLR2 and 
TLR4 on monocytes in unstimulated human umbilical cord blood, and also in a 
situation mimicking Gram-negative sepsis where the blood was stimulated with the 
lipopolysaccharide. Furthermore we wanted to study whether differences in gene 
14 
 
expression of the hyaluronan-binding proteins/receptors TLR4, CD44 and RHAMM 
in cord blood leukocytes could predispose to respiratory syncytial virus disease 
during the first 36 months of life. 
 
In the following “study I” refers to paper I, “study II” refers to paper II and “study 
III” refers to paper III. 
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2. Background 
 
2.1 Perinatal asphyxia 
 
Perinatal asphyxia is the single most important cause of brain injury in the newborn. 
WHO Child Health Epidemiology Reference Group (CHERG) reported that in 2000-
2003, asphyxia at birth accounted for 8% of the at that time 10.6 million yearly deaths in 
children younger than age 5 years (1). Later reports present similar estimates of birth 
asphyxia (9%) as the cause of deaths (2). Birth asphyxia ranks first among the perinatal 
insults that cause neurodevelopmental handicap in the newborn, particularly in the full-
term baby (3). 
 
Asphyxia features progressive hypoxia (inadequate oxygen supply to the cells and 
tissues) and hypercapnia (increased levels of carbon dioxide) with a significant metabolic 
acidosis. Hypoxia is caused by hypoxemia (low oxygen concentration in arterial blood) 
and/or ischemia (insufficient blood supply) (3). Two main characteristics of perinatal 
asphyxia are signs of cardiorespiratory and neurological depression, seen on a low Apgar 
VFRUHDWILYHPLQXWHVRUODWHU(4) and metabolic acidosis. A cut off point for defining 
pathological fetal acidaemia that correlates with an increasing risk of neurological deficit 
has been found to be an umbilical arterial cord pH of < 7.0 and/or BE < -12 mmol/l or < -
16 mmol/l (US and Canada) (5-7). 
 
A hypoxic-ischemic insult starts a cascade of events that ultimately may cause cell death and 
damage to the central nervous system. The mechanisms for neurodegeneration are not 
completely understood, but many interconnected pathways are involved in the process of 
brain injury. These events include depolarization of neuronal membranes, the production of 
reactive oxygen species leading to oxidative stress, lipid peroxidation, mitochondrial 
dysfunction leading to the activation of apoptotic pathways, an increase of neurotransmitter 
release and inhibition of uptake (including the excitatory amino acid glutamate), an increase 
of intracellular calcium, a decrease of blood flow, and the immunoinflammatory system (8-
10). The deprivation of oxygen and glucose play major roles in the initiation of the processes 
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leading to injury. Moreover, the period of reperfusion has been shown to be the time of 
occurrence of many of the deleterious consequences of ischemia on brain metabolism and 
ultimately structure. 
 
 
 
 
 
 
Figure 1. Pathophysiology of the fetal death due to asphyxia in pigs (simplified 
illustration) (11). 
Reprinted from Anim Reprod Sci 2005, Nov; 90(1-2):1-30.  
Copyright (2005) with permission from Elsevier. 
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2.2 Resuscitation with O2 
 
The concept of hypoxia-reoxygenation injury through oxygen free radicals was 
introduced by Saugstad and Aasen in 1980 (12), and since then, the use of oxygen for 
resuscitation has been subject to extensive search.  
 
Several studies had been performed on resuscitation of infants with 100% O2 versus 
room air when we started planning this project in 2006 (13-17). These 5 studies were 
reviewed by The Cochrane Collaboration in 2005. In the Cochrane review, the authors’ 
stated: “There is insufficient evidence at present on which to recommend a policy of 
using room air over 100% oxygen, or vice versa, for newborn resuscitation. (…)” (18) 
 
When we initiated our study in 2006, guidelines for resuscitation of neonates were last 
published in 2005 (19;20). Regarding the use of oxygen the guidelines differed slightly: 
The International Liaison Committee on Resuscitation (ILCOR) did not specify the 
concentration of oxygen to be used at initiation of resuscitation. They did however state 
that there was no evidence to support or refute a change in the oxygen concentration that 
was initiated, once adequate ventilation was established, and recommended that 
supplementary oxygen should be considered for infants with persistent central cyanoses 
(20). The American Heart Association recommended supplementary oxygen to be 
administered whenever positive-pressure ventilation was indicated, but they did open for 
the use of room-air if supplementary oxygen was not available (19).  
 
The international resuscitation guidelines are revised every five years. And in their 
guidelines from 2010, ILCOR now recommends to begin with air rather than 100% 
oxygen in term and near term infants receiving ventilation at birth (21), whereas the 
recommendation for preterm babies is still discussed. Since 2010, the European 
Resuscitation Council (ERC) guidelines advise oxygen saturation (SpO2) targets for the 
first 10 min of resuscitation after birth. These targets are based on observational studies 
of healthy term and preterm infants not needing any intervention during their 
resuscitation (22). During the first 10 min after birth, the SpO2 targets from the ERC 
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guidelines were advised, i.e. 60%, 70%, 80%, 85%, and 90% at 2, 3, 4, 5, and 10 min 
after birth, respectively (23). 
. 
Studies from our group had also been performed on newborn pigs. One study from 
Munkeby et al showed that resuscitation with 100% O2 increased metalloproteinase 
MMP-2 activity at both gene and protein levels, accompanied with cerebral leakage of 
glycerol, presumably triggered by augmented oxidative stress (24). Another study by 
Solberg et al. showed that supplementary oxygen used for the resuscitation of newborn 
pigs increased lipid peroxidation in brain cortical neurons, a result that is indicative of 
oxidative brain damage (25). These findings suggested that resuscitation of asphyxiated 
newborn pigs with 100% O2 was detrimental to the piglet brain compared with 
resuscitation with 21% O2.   
 
2.3 Free radicals  
 
Free radicals are molecules containing at least one unpaired electron. These highly 
reactive molecules or chemical species cause oxidative stress, which is defined as “an 
imbalance between oxidants and antioxidants in favour of the oxidants, potentially 
leading to damage” (26). Oxidative stress involves generation of RONS (reactive oxygen 
and nitrogen species, for example peroxynitrite) and ROS (reactive oxygen species, for 
example superoxide radical). There are numerous sites of oxidant generation, like 
phagocytic cells (the “respiratory burst”), mitochondrial electron transport, peroxisomal 
fatty acid metabolism and cytochrome P-450 reactions (27). 
 
Oxidative stress can damage lipids, proteins, enzymes, carbohydrates and DNA in cells 
and tissues. This can result in membrane damage, fragmentation or random cross linking 
of molecules like DNA, enzymes and structural proteins and even lead to cell death 
induced by DNA fragmentation and lipid peroxidation (27). In particular, peroxynitrite 
causes the nitration of tyrosine residues at the 3-position to produce 3-nitrotyrosine (3-
NT) (28). 
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The brain is very susceptible to oxidative damage due to the fact that the brain contains a 
high concentration of polyunsaturated fatty acids, which can easily undergo peroxidation, 
along with regions that are enriched in iron and low levels of endogenous antioxidants 
(29). The immature brain in particular has a reduced defence to deal with the production 
of reactive oxygen species, thus it is more susceptible to oxidative stress than the adult 
brain (30). 
 
During cerebral ischemia, the cut back in oxidative phosphorylation rapidly diminishes 
reserves of high-energy phosphates. Within a few minutes, considerable amounts of 
adenosine and hypoxanthine accumulate (31). During reperfusion these metabolic 
products are metabolised further by xanthine oxidase to produce xanthine and uric acid 
(32), but this is less likely to occur in the human brain. The breakdown of hypoxanthine 
by xanthine oxidase in the present of oxygen, produces a flood of superoxide radicals. 
These can be converted by superoxide dismutase (SOD, one of the body’s endogenous 
antioxidant enzymes) to hydrogen peroxide (33;34). 
 
The activity of xanthine oxidase in the resting brain is very low or minimal (35), but 
during cerebral ischemia a massive conversion of xanthine dehydrogenase to xanthine 
oxidase takes place in rats, regulated by the calcium-dependent protease calpain (36). 
However, in humans (including newborns) xanthine oxidase is probably only present in 
substantial amounts in the liver and intestine (37-39). In a study in newborn pigs, the 
release of xanthine oxidase did not seem to correlate with the severity of the histological 
brain damage after 4 days (40). Thus while xanthine oxidase and oxygen radicals have 
been implicated in hypoxic-ischemic brain injury in the newborn rat, xanthine oxidase 
could be less important in the asphyxiated human infant.  
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2.4 Intervention strategies and the antioxidant N-acetylcysteine 
(NAC) 
 
After perinatal asphyxia, there is a second phase of injury occurring from approximately 
6 to 48 hours after the initial incidence. This phase is characterized by a secondary energy 
failure (41). The therapeutic window is estimated to be between 2 and 6 hours after the 
insult (7;42). The goals of management of a newborn infant who has sustained a hypoxic-
ischemic insult and is at risk of injury should include early identification of the infant at 
risk for evolving injury, supportive care to facilitate adequate perfusion and nutrients to 
the brain, attempts to maintain glucose homeostasis, and consideration of interventions to 
ameliorate the processes of ongoing brain injury (43).  
Several intervention strategies were under investigation when we planned the study 
resulting in paper I. These included therapeutic hypothermia (44;45), xenon gas (46;47) 
and allopurinol (48;49). In this thesis I will not describe all the different strategies, but 
focus on the antioxidant N-acetylcysteine (NAC). 
NAC is a well-known antioxidant and free radical scavenging agent, and is able to cross 
the placenta and the blood-brain barrier (50). It is considered safe during pregnancy (51-
54). Glutathione (and the cycle leading to its synthesis), is one of the most important 
intracellular antioxidant systems (55). Most cells possess enzymes for glutathione 
synthesis from cysteine, glutamate and glycine, but the capacities vary (55). In preterm 
infants especially, glutathione synthesis is impaired because of a developmental 
deficiency of cystathionase activity, leading to extremely low levels of available free 
cysteine (55;56). L-cysteine is essential for the synthesis of glutathione, and NAC is a 
source of L-cysteine that bypasses cystathionase. 
In the process of preparing paper I, several papers were published describing the use of 
NAC, showing that administration of NAC reduced cerebral oxidative stress and 
improved cardiac function and renal perfusion in porcine models of neonatal hypoxia 
(57-60). In these studies, NAC was given as an intravenous bolus of 150 mg/kg 
21 
 
(57;59;60) or 30 mg/kg (58) at 5 or 10 minutes of reoxygenation, followed by an infusion 
of 100 mg/kg/h (57)or 20 mg/kg/h (58-60).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
22 
 
2.5 Hyaluronan (HA) 
 
Hyaluronan (HA), also called hyaluronic acid or hyaluronate, is a glycosaminoglycan 
(GAG). GAGs are large complexes of negatively charged heteropolysaccharide chains. 
They are generally associated with a small amount of protein, forming proteoglycans. 
Proteoglycans typically consist of over 95 percent carbohydrate. HA, however, is a 
unique GAG in that it is non-sulfated and not associated with protein. 
  
HA is a major component of the extracellular matrix (61). Because of its physical 
properties, HA imparts stiffness and resilience as well as a lubricating quality to many 
types of connective tissue such as joints. Because of the large number of anionic residues 
on its surface, HA binds a large amount of water and forms, even at low concentrations, a 
viscous hydrated gel. If stretched end-to-end, one molecule of HA would be 20 mm long. 
Overall, however, HA is not a long, rigid rod as is collagen; rather, in solution it behaves 
as a random coil about 500 nm in diameter.                                             
 
Over the past decades, evidence has accumulated that HA serves important biological 
roles beyond its generally accepted function as a structural component of interstitial and 
connective tissue. For instance, HA has been shown to promote wound healing (62;63), 
tumor transformation, and metastasis (64-66), as well as cell motility and migration (67-
70). Because of its loose, hydrated, porous nature, the HA "coat" bound to cells appears 
to keep cells apart from one another, giving them the freedom to move about and 
proliferate. It is also an important mediator of inflammation (71;72). Many of these 
biological activities are mediated by either the receptor CD44 or the receptor for HA-
mediated motility (RHAMM or CD168). RHAMM is expressed in a variety of 
mammalian cells, including at the apex of ciliated airway cells. HA can also signal 
through the receptor intracellular adhesion molecule-1 (ICAM-1/CD54), and through 
Toll-like receptors 2 (TLR2) and 4 (TLR4). 
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2.5.1 HA and inflammation  
 
HA is an important mediator of inflammation. HA regulation of inflammation is both 
dose- and molecular size-dependent.  
 
High molecular weight HA (HMW HA, ~1-2 x 106 Da) has been reported to inhibit 
inflammatory cell chemotaxis, phagocytosis and elastase release (73-77). On the other 
hand, at lower concentrations and at lower molecular weight (LMW HA, < 500-700 
kDa), HA promotes monocyte maturation into macrophages as measured by production 
of insulin-like growth factor-1 (78;79), and HA is greatly increased during inflammatory 
conditions such as myocardial infarction (80), arthritis (81) and during transplant 
rejection (82-84). Furthermore, removal of HA with early treatment of myocardial 
infarction with hyaluronidase results in reduced myocardial fibrosis and infarct size, both 
in human and in animal studies (85-87).  
 
LMW HA and HA oligosaccharides have been shown to increase gene expression of 
proinflammatory chemokines and iNOS in macrophage cell lines as well as in alveolar 
macrophages from injured mice (72) and in microglia (88). Superoxide and peroxynitrite 
have both been shown to break down HMW HA into LMW HA (89-95). HA is an 
endogenous TLR4 ligand, and fragments of HA can stimulate chemokine/cytokine 
production in macrophages by signalling through TLR4, TLR2 and the adaptor molecule 
MyD88 (96). 
 
In the following, if not otherwise specified, HA denotes both LMW and HMW HA. But 
in general LMW HA, generated during active inflammation, is an endogenous “danger 
signal,” and HMW HA, predominant in healing or intact tissues, functions in an inverse 
manner. 
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2.5.2 HA in the lung  
 
In the lung, HA is mainly located in the peribronchial and interalveolar/perialveolar 
tissue (97), and is involved in cell-cell interactions, cell-matrix interactions, cell 
proliferation, tissue hydrodynamics, cell locomotion and inflammation (67;71;98;99). HA 
also serves a role in airway mucosal host defense. Enzymes are retained at the apical 
surface of the airway epithelium by binding to surface-associated hyaluronan, providing 
an apical enzyme pool and protected from ciliary clearance. HA binding to RHAMM 
stimulates ciliary beating (100).  
 
Interaction of RHAMM with HA is a critical component of the recruitment of 
inflammatory cells to the lung after injury (71;101). An increased recovery of HA in 
bronchoalveolar lavage (BAL) has been found in various disease states such as ARDS 
(102;103).  
 
HA is synthesized by at least three HA synthases (HAS1, HAS2 and HAS3) (104), and 
HA synthase expression is altered in a number of lung pathologies (105-107). 
Degradation products of HA is produced under inflammatory conditions, during tissue 
injury and by oxidative stress (89;91). It is also degraded by hyaluronidases (108). The 
lower-molecular-weight fragments of HA are implicated in several lung diseases, 
including asthma, pulmonary hypertension and acute lung injury (109). 
 
Other findings in studies prior to our study in 2006 (resulting in paper I): 
 
x Lung HA concentration had been measured in newborn infants who died within 
228 days of birth. The HA concentration in the lung decreased with increasing 
gestational age. Intrauterine infection was also associated with a significantly 
higher lung HA concentration (110) 
x It had also been shown that HA concentrations in lung extracts of premature 
monkeys increased with progressively severe RDS (111).  
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x Lung hyaluronan decreased during group B streptococcal (GBS) pneumonia in 
neonatal piglets. Atelectasis plus lobar pneumonia further decreased lung HA. It 
was known that GBS virulence factors include specific secretory enzymes such as 
hyaluronidase, an enzyme which breaks down HA (112).  
x Aerosol administration of HA (molecular weight variable from 400 to 4000 kDa) 
significantly reduced the bronchial hyperreactivity to muscular exercise in asthma 
in one study (113). In later studies, aerolized HA has been proposed to have a 
theurapeutic potential in the treatment of lung diseases like cystic fibrosis (114) 
and smoke-induced lung injury (115;116).  
x Johnsson et al exposed rabbit pups to either room air or hyperoxia (>85%) 
neonatally. They found that hyperoxia resulted in an increase in lung HA 
accompanied by an increase in lung water content (117). It had also been shown 
that hyperoxia caused an increase in lung HA and lung water in neonatal rat pups 
(118). 
 
In the recent years, the role of HA in lung disease has been summarized in several good 
reviews (97;109;119;120).  
  
HA and surfactant  
HA has been shown to decrease surfactant inactivation in vitro (121). HA has also been 
shown to reduce surfactant inhibition and improve rat lung function after meconium 
injury (122). Wang et al published a study where ventilated premature piglets with 
respiratory distress were given HA-fortified surfactant. They concluded that HA added to 
50 mg/kg Curosurf or use of 100 mg/kg Curosurf with or without HA provided the best 
effects in terms of lung function and reduction of inflammation (123). 
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2.5.3 HA in the serum and urine  
 
The serum level of HA is regulated by the influx of the polysaccharide from the tissues 
via lymph and its receptor –mediated clearance by liver endothelial cells. Only 1% of the 
circulating HA is recovered in urine (124). The half-life of circulating HA in healthy 
adults is 2,5 – 5,5 min (125). Serum HA is increased in certain liver diseases, especially 
in patients with cirrhosis, when the clearance is impaired. The serum level also increases 
in rheumatoid arthritis, in other inflammatory diseases, and it is of special interest that 
high HA levels in patients with septic conditions is a sign of poor prognosis. Certain 
tumors, notably Wilms’ tumor and mesothelioma, produce factors which activate 
synthesis of HA and increase its serum level. Rare hereditary diseases with disturbances 
of HA metabolism and elevated blood levels have also been discovered, e.g. Werner’s 
syndrome and cutaneous hyaluronanosis (126-128).  
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2.6 Neonatal sepsis 
 
WHO and UNICEF Child Health Epidemiology Reference Group reports that in 2008, 
neonatal pneumonia or sepsis was estimated to account for 10% of the 8.795 million 
yearly deaths in children younger than age 5 years worldwide (2). 
 
Trends in sepsis-related neonatal mortality from 1985 to 1998 in the United States have 
been analyzed: early neonatal mortality from sepsis decreased, on average, from 24.9 to 
15.6 deaths per 100 000 live births between the 2 time periods with a greater average 
annual percent decline from 1995 to 1998 compared with 1985 – 1991. This suggests an 
association with Group B Streptococcus (GBS) disease prevention efforts and new 
guidelines concerning intrapartum antibiotic prophylaxis (129;130). In contrast, late 
neonatal mortality from sepsis increased slightly from 14.8 to 16.2 deaths per 100 000 
early neonatal survivors (131). Late-onset sepsis caused by Escherichia coli (E. 
coli)/gram-negative bacilli has increased in some studies from the U.S. (132;133).  
 
GBS and E. coli are the most common pathogens associated with early onset sepsis in the 
United States (134;135). Population-based surveillance from 2005 to 2008 conducted 
through the Active Bacterial Core sites identified 658 cases of early onset sepsis from 
2005 to 2008; 72 (11%) were fatal. Overall incidence remained stable during the 3 years 
at 0.76 to 0.77 cases/1,000 live births. GBS (38%) was the most commonly reported 
pathogen followed by E. coli (24%) (136). GBS remains the most frequent pathogen in 
term infants, and E. coli the most significant pathogen in preterm infants (135). In spite of 
medical advances, E. coli and other gram-negative bacilli remain responsible for 
significant morbidity and mortality, especially in very low birth weight infants (133;137) 
(138;139).  
 
Septic shock in the neonatal period has a very poor outcome. An article in Pediatric 
Critical Care Medicine shows a 28-day mortality of 40%. Adverse outcome at 18 months 
of corrected age was observed in 24 of 46 infants (52%; death =19, severe sequelae=5) 
(140).  
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The increased susceptibility to infection in the neonatal period appears to be due to 
immaturity of the immune system. The neonatal immune system lacks pre-existing 
memory and shows decreased Th1-type responses (141-148).  
 
 
2.7 Toll-like receptors 
 
Toll-like receptors (TLRs) that can be found on monocytes are key components of the 
innate immune system. They play a central role in the detection of invading pathogens. 
The german scientist Christiane Nüsslein-Volhard gave name to this pattern recognition 
receptor (PRR) family (149). Her group found weird-looking larva with under-developed 
ventral portion of the body when they were studying gene mutations in fruit flies. “Das 
war ja toll (that is amazing/great)!” was her spontaneous comment when seeing the effect 
on the larva, and she named the mutated gene Toll (150). Jules Hoffmann’s group 
described the role of Toll in the immune defence as they found it to have an essential role 
in the fly's immunity to fungal infection (151). Bruce A. Beutler and colleagues 
discovered that TLR 4 function as a lipopolysaccharide (LPS) sensing receptor (152). 
Christiane Nüsslein-Volhard, Bruce A. Beutler and Jules Hoffmann have all been 
awarded the Nobel Prize in Medicine or Physiology for their work (Nüsslein-Volhard in 
1995, Beutler and Hoffmann in 20011). 
 
Of the TLRs, TLR4 is the most characterised, and as written above, it is known to 
respond to LPS, which is the major component of the outer membrane of Gram-negative 
bacteria (153). TLR4 is also involved in recognition of respiratory syncytial virus (RSV) 
fusion proteins (154). TLR2 has the ability to detect various microbial components, such 
as components of Gram-positive bacteria, mycobacteria and fungi, and this receptor can 
form a heterodimer with TLR1 or TLR6 (155-158). Polymorphisms in TLR4 may 
predispose people to develop septic shock with gram-negative microorganisms (159), and 
to severe RSV bronchiolitis (160), while polymorphisms in TLR2 have been associated 
with Gram-positive infections in a study of preterm infants (161). 
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TLR signaling is divided into two distinct signaling pathways, the MyD88-dependent and 
TRIF-dependent pathway (see figure 2). 
In several studies, newborn basal expression of TLR2 and TLR4 has been equivalent to 
adult levels (145;162). By contrast, others have found significantly lower expression of 
TLR4 (163) or TLR2 (164) on neonatal monocytes compared to adult levels.  Sadeghi et 
al. did a study on monocytes from preterm infants. They found increasing TLR4 
expression with gestational age, and significantly lower expression of the proximal 
downstream adaptor molecule myeloid differentiation factor 88 (MyD88) in preterm 
infants (163). A recently published study by Shen et al. shows that the blood monocytes 
of preterm newborns display rapid increase in TLR2 and TLR4 expression during the 
first few months of life, whereas LPS-induced cytokine production functionality did not 
improve in parallel (165). In recent years, an association between TLR polymorphisms 
and prematurity have been described (166;167), giving new insight into the significance 
of the human newborn innate immune system.  
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Figure 2. Overview of LPS/TLR4 signalling pathway. LPS recognition is facilitated by 
LPS binding protein (LBP), and Cluster of differentiation 14 (CD14), and is mediated by 
a TLR4/ Myeloid differentiation protein-2 (MD-2) receptor complex. LPS/TLR4 
signalling can be separated into MyD88-dependent and MyD88-independent pathways, 
which mediate the activation of proinflammatory cytokine and Type I interferon genes.  
TIR: Toll/IL-1 receptor 
TIRAP: TIR-associated protein 
TRAM: TRIF-related adapter molecule 
TRIF: TIR-domain-containing adapter-inducing IFN-ß 
 
Reprinted from Cytokine, May 2008; 42(2):145-51 (168). Copyright (2008), with 
permission from Elsevier. 
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2.8 Respiratory syncytial virus (RSV) infection  
 
The fact that RSV responses may be mediated through the monocyte TLR4 receptor 
inspired our study on susceptibility to RSV infection in infancy (paper III). RSV is a 
significant human pathogen causing lower respiratory infections among infants and 
young children worldwide (169). During 1997-2006, an estimated 132,000-172,000 
children aged < 5 years were hospitalized for RSV infection annually in the United States 
(170).  
Cellular responses to RSV in vivo and in vitro have been summarized in several good 
reviews (171-174). In this thesis I am interested in HA and its interactions. Increased 
tissue degradation of HMW HA is implicated in the pathology of asthma, a condition 
commonly associated with RSV infection (109). In paper III my focus was therefore on 
the receptors TLR4, CD44 and RHAMM that regulate HA interactions, and which are 
likely to be involved in the immune response to RSV (96;100;175). The research group 
as a whole (paper III) was also interested in other genes that have important functions in 
both the innate and adaptive immune systems, and that are implicated in the immune 
response to RSV, and studied gene expression of IL7R, CCR7 , CXCL7, IL4, IFNG, 
CCL3, CXCL11 and CXCR3. 
 
Polymorphisms in TLR4 may predispose children to severe RSV bronchiolitis (160). 
From the literature it is known that CD44 variant 6 (CD44v6) is upregulated in bronchial 
smooth muscle cells of asthma patients (176). One study by McCurdy et al. showed that 
RSV proteins colocalized with CD44 and a few other cellular proteins associated with 
lipid microdomains. This is thought to lead to critical interactions necessary for the 
formation of filamentous virus particles and syncytium formation (177). It has also been 
shown that mononuclear leukocytes preferentially bind via CD44 to hyaluronan on 
human intestinal mucosal smooth muscle cells after RSV infection (175). HA binding to 
RHAMM expressed at the apex of ciliated airway epithelial cells stimulates ciliary 
beating, and thus has a role in airway mucosal defense (100). Increased expression of 
Has1 and Has2 in lung tissue was found in a murine model of asthma (106).  
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3. Aims of the study 
 
Perinatal asphyxia, neonatal sepsis and RSV infection are major causes of morbidity and 
mortality among infants and toddlers. We wanted to clarify the biological relevance and 
activities of hyaluronan and its receptors/hyaluronan-binding proteins in relation to these 
clinical settings, and study the effect of resuscitation with 100% oxygen on hyaluronan in 
the neonatal lung. We wanted to investigate the following issues: 
x Would resuscitation with 100% oxygen versus room air cause more hyaluronan 
degradation in the neonatal lung? We hypothesized that exposure to 100% O2 
during neonatal resuscitation would result in increased peroxynitrite production, 
fragmentation of HA and an increased inflammatory response (paper I).  
x Would antioxidant treatment with NAC prevent a possible degradation of HA? 
x We wanted to measure the HA content in serum and BAL after asphyxia, and 
hypothesized that we would find an increase in HA content in both serum and 
BAL.  
x Would the presence of HMW- or LMW HA alter the monocyte surface expression 
of TLR2- and TLR4, or the cytokine production, in an ex vivo neonatal whole 
blood model? We hypothesized that the presence of LMW HA would increase the 
surface expression of TLR4, and that we would find a reduction in TLR4 
expression on monocytes (paper II).         
x We also aimed to explore whether differences in gene expression of the 
hyaluronan-binding proteins/receptors TLR4, CD44 and RHAMM in cord blood 
leukocytes could predispose to respiratory syncytial virus disease during the first 
36th months of life (paper III).  
In figure 3 the TLR4 ligands HA, RSV and LPS are shown, these are in focus in study II 
and III.  
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Figure 3. Ligands for TLR4 include both exogenous ligands, such as LPS, the fusion 
protein of RSV and bacterial fimbriae, and endogenous ligands, such as HA, ß-defensin 
and heat-shock protein 60 (HSP60). These ligands do not seem to have common 
structural motifs. Blue colouration indicates hydrophobicity.  
Reprinted with permission from Nature Reviews Immunology 4, 469-478 (June 2004)  
(178) 
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4. Materials and methods 
 
 
4.1 Ethical considerations 
 
The animals in study I were cared for and handled in accordance with the European and 
NIH (National Institutes of Health) Guidelines for Use of Experimental Animals, by 
certified FELASA (Federation of European Laboratory Animals Science Associations) 
category C and UT Southwestern researches. The Norwegian Council for Animal 
Research and the University of Texas Southwestern Medical Center Institutional Animal 
Care and Utilization Committee approved the experimental protocol.  
The Regional Committee for Medical Research Ethics in Norway (Region South East) 
approved study II and III. In study II written consent for sampling of cord blood was 
given by the parents after written and verbal information by the first author. In study III 
oral and written informed consent for further studies were given by the parents both at 
birth and when the child was hospitalized with acute bronchiolitis during infancy or when 
attending the follow-up visit at age one year for the controls. 
 
4.2 The animal model (paper I) 
 
It is difficult to study the pathophysiology of neonatal asphyxia in humans. Neonatal 
hypoxic-ischemic injury has therefore been studied in a variety of animal models. Animal 
models will always be an approximation of the clinical situation of interest.  
 
The newborn pig model is a popular model due to several reasons. The newborn pigs 
resemble humans in anatomy and physiology of the cardiovascular system (179;180). In 
addition to size and morphological characteristics, there are physiologic similarities in the 
areas of coronary blood flow (181), distribution of the grey/white matter, changes in 
brain morphology during development (182), growth of the cardiovascular system, and 
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neonatal pulmonary development (180). Both in human infants and in animal models, the 
localisation and extent of the injury observed will not only depend on the degree and 
duration of the insult, but also on the maturity of the brain, lungs and heart (183;184).  
 
We used Noroc pigs in our study. These are a crossbreed between Norwegian Landrace 
(½), Yorkshire (¼) and Duroc (¼). Newborn pigs (12-36 hours old) were transported 
from a local farm on the day of the experiment. The pigs were taken from their mother as 
late as possible on the experiment day to avoid dehydration and stress. They were 
transported in a warm incubator to avoid hypothermia. Exclusion criteria’s were arterial 
haemoglobin < 5 g/dl, and reduced general condition. Desired weight was 1.5 – 2.0 kg 
approximately. Total blood volume in a pig is 70 ml/kg body weight and it was possible 
to withdraw a maximum of 10% blood on the day of the experiment. 
 
Illustration made by Øystein H. Horgmo, Medical Photography Section, University of 
Oslo. 
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4.2.1 Anaesthesia 
 
The animals were weighed and handled when awake, using heated towels and calm 
surroundings to minimize stress. Anaesthesia was induced by sevoflurane 3-5% 
(Sevorane, Abbott) mixed with ambient air and oxygen, and was disconnected when an 
ear vein was cannulated, usually within two-three minutes. The pigs were then given 
pentobarbital (50 mg/ml) 15-20 mg/kg, midazolam (5mg/ml) 0.5 mg/kg and fentanyl (50 
μg/ml) 50 μg/kg intravenously as a bolus injection.  
 
Anaesthesia was maintained by a continuous infusion of fentanyl (50 μg /kg /h) and 
midazolam (0.25 mg/kg/h IVAC P2000 infusion pump). When necessary, a bolus of 
fentanyl (50 μg/ml) 50 μg/kg, midazolam (5 mg/ml) 2.5 mg/kg or Pavulon (2mg/ml) 0.1 
mg/kg was added. The need for medication was defined as shivering, trigging on the 
respirator, increased muscle tone and reflexes, increase in blood pressure and/or pulse.  
 
4.2.2 Procedure  
 
The pigs were ventilated with a pressure-controlled ventilator (Babylog 8000+; 
Drägerwerk, Lübeck, Germany) to achieve normoventilation (arterial carbon dioxide 
tension (PaCO2) 4.5–6.0 kPa, except during hypoxia) and a tidal volume of 8-12 mL/kg.  
Inspired fraction of O2 and end-tidal CO2 were monitored continuously (Datex 
Normocap Oxy; Datex, Helsinki, Finland). They were intubated orally, placed on their 
back and washed for sterile procedures. Then they got an arterial and a venous catheter. 
Nutrition and fluid were maintained by giving the pig salidex i.v. (glucose 35 mg/ml, i.e. 
3.5%) as a continuous infusion throughout each experiment 10 ml/kg/hour. Mean arterial 
blood pressure and blood gases were monitored throughout the experiment. Pulse 
oximetry monitor measured pulse and SaO2. Rectal temperature was maintained between 
38.5°C and 40°C with a heating blanket and a radiant heating lamp.  
 
At the end of the experiment, the pigs were given an overdose of 150 mg/kg pentobarbital 
intravenously. Bronchoalveolar lavage (BAL) and plasma samples were obtained, and 
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tissues were quickly removed, snap frozen in liquid nitrogen, and stored at -70°C until 
subsequent analysis. 
 
4.2.3 Experimental group 
 
After intubation and surgical procedures, the pigs had a stabilization period of 60 
minutes. Control animals were then euthanized prior to asphyxia. The rest were subjected 
to global hypoxia and given 8% O2 in nitrogen until BE < -20 mmol/L and/or MAP 15 
mmHg. During hypoxia, CO2 was added at a PaCO2 8.0–9.5 kPa, aiming to imitate birth 
asphyxia. A post asphyxia group was harvested prior to any resuscitation. 
The rest of the pigs were resuscitated with either 21% or 100% O2 for 30 min, and then 
observed for a further 150 min after resuscitation when all pigs were maintained in 21% 
O2. In separate experiments, as described previously (59;60), an additional group of 
animals exposed to 30 minutes of 100% O2 resuscitation were treated with a bolus of 150 
mg/kg N-acetylcysteine (NAC) starting at the onset of 100% O2 resuscitation followed 
by a 20 mg/kg/h infusion for the duration of the experiment. 
 
4.3 Murine macrophage cell line (paper I) 
 
In study I, we also stimulated the murine macrophage cell line RAW264.7 by various 
concentrations of HA6, the number 6 indicating a six sugar oligosaccharide, for 24 hours. 
The supernatant was spun to clear cells and stored at -80 °C for later tumor necrosis 
factor-Į71)-Į determination. The cells were harvested and Interleukin-1 ß (IL-1 ß) 
concentrations determined in equal amounts of protein lysate. 
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4.4 Human umbilical cord blood (paper II and III) 
 
4.4.1 The ex vivo whole blood model (paper II) 
 
 
Mononuclear phagocytes and neutrophils are crucial cellular components of the innate 
immune response. Monocytes are mononuclear phagocytes within the blood stream 
where they circulate for 1 to 3 days (185). Monocytes have retained proliferative capacity 
and can differentiate into a variety of tissue resident macrophages throughout the body, as 
well as specialised cells such as dendritic cells and osteoclasts (186;187). We chose this 
model in order to study monocytes in their natural habitat and to mimic an in vivo 
condition of acquired E. coli sepsis. 
 
The whole blood model has been described previously (188-190). It is a useful tool for 
investigating immunomodulating effects on a white blood cell population. Wang et al. 
showed that leukocyte counts in this model were stable throughout the experimental 
periode: leukocyte viability exceeded 98% after 14 h of incubation (190).  
 
Human umbilical cord blood (HUCB) for study II was obtained by venopuncture of the 
umbilical vein immediately after delivery by elective caesarean sections, and collected 
directly into lithium heparin-containing vacutainers (after informed consent). All 
specimens were processed within 1 hour. The cord blood was aliquoted into sterile 5 ml 
polystyrene tubes for different stimulations and incubation times. Some of the blood was 
not stimulated (referred to as control blood), the rest was incubated with either LPS 
and/or HA for 3- or 6 hours, as described in paper II. The tubes were incubated in room 
air at 37 °C, and gently rotated to avoid cell sedimentation. The blood was analysed by 
flow cytometry and with different immunoassays.  
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4.4.2 The Akershus Birth Cohort (paper III) 
 
 
The Akershus Birth Cohort has previously been well described (191). 2108 cord blood 
samples were collected into Paxgene collection tubes for RNA analysis, into EDTA tubes 
for later DNA analysis, and into serum tubes for later serum protein analysis. Cross-
referencing the cohort with our microbiology database, we identified infants in the cohort 
who later (before 36 months of age) presented with a positive RSV nasopharyngeal 
aspirate. Individuals who did not have a positive RSV test were randomly selected from 
the cohort as controls. We then studied gene expression and performed protein analyses 
as described in the following sections. 
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4.5 Laboratory analyses 
 
4.5.1 Immunostaining (paper I) 
 
Immunohistochemistry is a combination of an immunoreaction identifying a specific 
protein/substance in a selected tissue, and the detection of that reaction using light 
microscopy. The principle is binding of an antibody to an antigen in the tissue-sample, 
either direct (using a labelled primary antibody) or indirect (with secondary antibodies, 
where a primary antibody is first attached to the antigen). The staining can be performed 
with immunoenzyme-techniques, or immunofluorescence. Immunofluorescence requires 
specialized microscopes for evaluation. 
 
The immunostaining of lung tissue in paper I was performed on 5 μm paraffin-embedded 
sections, and indirect dual immunofluorescence for 3-nitrotyrosine (3-NT) and HA was 
performed as described in the paper. Sections were visualized using fluorescence 
microscopy, and we used DAPI (a fluorescent stain) for nuclei staining.  
 
4.5.2 Enzyme-linked immunosorent assay (ELISA) (paper I and II) 
 
To measure concentrations of tumor necrosis factor-Į71)-ĮDQGLQWHUOHXNLQ-1 ß (IL-1 
ß) (paper I, II), and Interleukin-8 (IL-8) and matrix metallopeptidase 9 (MMP9) (paper 
II), we used commercially available ELISA kits. This is a method that provides a specific 
and highly sensitive technique for quantification of molecules in a solution, and it is 
based on the principle of protein binding by specific antibodies combined with an 
enzyme-induced chromogenic reaction. In short, standards and samples are pipetted into 
the wells of a microplate precoated with a monoclonal antibody of interest. The protein is 
bound to the immobilised antibody, and after washing away all unbound substances, a 
second, enzyme-linked antibody against the protein, making a sandwich complex, is 
added to the wells. Subsequently, a substrate solution is added, and a colored product is 
created in proportion to the quantity of protein present in the samples or standards. The 
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absorbance is measured by a microplate reader, and the protein concentrations are 
obtained by extrapolation from a standard curve.  
 
ELISA-like assay for HA (paper I) 
 
HA content in BAL and serum was determined by an ELISA-like assay as described 
previously (101). This ELISA measures the competition of HA present in the sample 
versus HA coated on a 96-well plate for binding to biotinylated HA-binding protein. 
 
4.5.3 Tissue water content and determination of HA size (paper I) 
 
Wet and dry weights of lung tissue were taken before and after lyophilisation, 
respectively, and tissue water content was calculated by substracting dry and wet weight 
ratio from 1. Lyophilized tissues were then treated as described in the Materials and 
Methods section in paper I, and an agarose gel electrophoretic method for analysis of HA 
molecular weight distribution was used. 
 
4.5.4 Quantitative reverse transcription polymerase chain reaction 
(Quantitative RT-PCR) (paper I and III)  
 
This is a technique commonly used in molecular biology to detect RNA expression 
levels, and is one of many variants of polymerase chain reaction (PCR). Real-time 
reverse transcription polymerase chain reaction (RT-qPCR) has become the method of 
choice for the quantification of mRNA. It is a combination of three steps: (i) the reverse 
transcriptase (RT)-dependent conversion of RNA to cDNA, (ii) the amplification of the 
cDNA using the PCR and (iii) the detection and quantification of amplification products 
in real time (192).  
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4.5.5 Flow cytometry (paper II) 
 
Flow cytometry (FCM) is a means of measuring certain physical and chemical 
characteristics of cells or particles as they pass in a fluid stream by a beam of laser light. 
The term "flow cytometry" derives from the measurement (meter) of single cells (cyto) as 
they flow past a series of detectors. Flow Sorting extends flow cytometry by using 
electrical or mechanical means to divert and collect cells with one or more measured 
characteristics falling within a range or ranges of values set by the user. The major 
applications of FCM include the analysis of cell cycle, apoptosis, necrosis, multicolor 
analysis, cell sorting, functional analysis and stem cell analysis, etc. We did an 
immunofluorescent study. 
 
When the cells pass through the laser intercept, they scatter the laser light according to 
physical characteristics (like size and granulation). In addition, any fluorescent molecule 
bound to the cell will show fluorescence. The scattered and fluorescent light is collected 
by lenses, and according to wavelengths routed to the appropriate detectors by 
combinations of mirrors and optical filters. Voltage pulses are amplified and converted to 
digital numbers which can be displayed on data plots. The forward scatter channel (FSC) 
collects light scattered in the forward direction, and its intensity represents an estimate of 
the cell size. Light scattered approximately at a 90° angel to the exitation line is detected 
in the side scatter channel (SSC), and the intensity is correlated to the granulation of the 
cells. By combining FCS and SSC intensity it is possible to separate different cell types, 
e.g. blood leukocyte subsets. 
 
In study II we used monoclonal antibodies against cluster of differentiation 14, -45 
(CD14, CD45), TLR2 and TLR4. CD14 was conjugated with the fluorochromes 
fluorescein isothiocyanate (FITC), TLR2 and TLR4 with phycoerythrin (PE) and CD45 
with peridinin chlorophyll protein complex (PerCP).  
 
We defined the monocytes according to their CD14-staining and side scatter light 
characteristics. 5000 monocytes were acquired with the help of an electronic gate in each 
sample. The FACSCanto II flow cytometer (BD Biosciences) equipped with FACS Diva 
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Software version 6.1.3 (BD Biosciences) was used for the analysis. The median 
fluorescence intensity (MFI) was recorded and corrected for non-specific antibody 
binding by subtracting the MFI measured for the matched isotype control sample. 
 
4.5.6 mRNA microarray (paper III) 
 
Microarray analysis can detect the simultaneous expression and interactions of thousands 
of genes (193). 
 
A microarray works by exploiting the ability of a given mRNA molecule to bind 
specifically to, or hybridize to, the DNA template from which it originated. By using an 
array containing many DNA samples, scientists can determine, in a single experiment, 
the expression levels of hundreds or thousands of genes within a cell by measuring the 
amount of mRNA bound to each site on the array. With the aid of a computer, the amount 
of mRNA bound to the spots on the microarray is precisely measured, generating a 
profile of gene expression in the cell. 
 
In planning study III this technology was used as a hypothesis-generating tool to identify 
some of the most differentially expressed genes and gene sets, but the HA binding 
proteins TLR4, CD44 and RHAMM were chosen without using this technology. 
 
4.5.7 Western blot analyses (paper III) 
 
Western blot analysis (also called immunoblotting because an antibody is used to 
specifically detect its antigen) was introduced by Towbin et al. in 1979 and is now a 
routine technique for protein analysis. It uses gel electrophoresis to separate proteins by 
3-D structure or denatured proteins by the length of the polypeptide. The proteins are 
then transferred to a membrane (typically nitrocellulose or PVDF), where they are stained 
with antibodies specific to the target protein. 
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4.6 Statistical analyses 
 
 
In paper I differences among groups of animals were analysed using one-way Analysis of 
Variance (ANOVA). When statistically significant differences were found (p<0.05), 
individual comparisons were made using the Bonferroni/Dunn tests. 
 
In paper II the flow cytometric data were tested for normality using normal probability 
plots. Thereafter differences between mean values were estimated with 2-tailed Paired-
Samples T test. Differences between mean cytokine- and protease concentrations were 
estimated using the Wilcoxon signed-ranks Test for paired samples (exact method, 2-
tailed), since they were not normally distributed. P-values < 0.05 were considered 
statistically significant. 
 
Paper III. RT-qPCR results were assessed for normal distribution using the Kolmogorov-
Smirnova and Shapiro-Wilk tests. Normally distributed data were calibrated to the mean 
of the control group and analysed using Student’s T-test. When data were not normally 
distributed, they were calibrated against the median of the control group and analysed 
using the Mann-Whitney or Kruskal-Wallis test, as appropriate. The median difference 
between control and RSV disease groups was calculated using the Hodges–Lehmann 
estimator. Mean or median differences were first calculated for ǻǻ&WYDOXHVDQGWKHQ
converted to relative quantities. Subgroup analysis for severity of disease was carried out 
using One-way ANOVA or the Kruskal-Wallis test, as appropriate, with post-hoc 
analysis for individual groups vs. control. For protein analysis, a target protein to CD45 
ratio was calculated for each sample to correct for variations in sample contamination. 
Ratios were log transformed to give a normal distribution and analysed using Student’s 
T-test. Correcting for the 11 genes included in the experiment, we considered p < 0.0045 
to be statistically significant. 
  
 
45 
 
5. Summary of results 
 
 
Paper I 
This study included 40 newborn pigs, and there were no significant differences between 
groups with respect to body weight, age, gender, haemoglobin and baseline 
hemodynamic- and pulmonary parameters. The 32 animals that were subjected to 
hypoxia showed similar degrees of compromise at the end of the asphyxia period in both 
the 21% and 100% O2 resuscitation groups.  
 
In this study, we found that exposure to 30 minutes of 100% and not 21 % O2 during 
resuscitation is associated with increased peroxynitrite and LMW HA content in the lung. 
$QLQFUHDVHLQLQIODPPDWRU\FHOODFFXPXODWLRQDQGHODERUDWLRQRI71)ĮDQG,/ZDV
noted in animals that had LMW HA in the lung. Treatment with NAC was associated 
with decreased peroxynitrite, preserved HMW HA and less inflammatory cell 
accumulation and cytokine expression. In cultured murine macrophages, peroxynitrite 
was able to degrade HMW HA to LMW HA, and oligomeric HA was able to stimulate 
71)ĮDQG IL1ß production. 
 
At the end of asphyxia, the HA content of BAL decreased and that in the serum 
increased. BAL HA was significantly increased in animals resuscitated with 100% O2 
and this increase was completely inhibited by treatment with NAC. 
 
Paper II 
 
Concentrations of all cytokines and MMP9 increased significantly when we stimulated 
the blood with LPS (P< 0.0005 for all), indicating an activation of the blood cells in our 
model.  
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Our results showed a significant decrease in monocyte TLR4 expression in the presence 
of HMW HA. Median fluorescence intensity, MFI, was 141 ± 7.3 in the presence of 
HMW HA, vs. 163 ± 9.8 in control blood (P= 0.019).  
 
There were no significant changes in TLR2 expression on monocytes between control 
blood and the different stimulations, thus no evidence of HA (neither HMW HA nor 
LMW HA) having modulating effect on monocyte TLR2 expression. 
 
When the HUCB was incubated with HMW HA for 3- and 6 hours, there were significant 
increases in concentrations of several proinflammatory cytokines and MMP9, and LMW 
HA had the same impact at 6 hours. In LPS-stimulated cord blood we measured 
significant increases in levels of several cytokines and MMP9 (6 h) after exposure to 
HMW HA, whereas the presence of LMW HA reduced the LPS-induced increments of 
MMP9 and IL-VLJQLILFDQWO\ZKLOHWKHFRQFHQWUDWLRQRI71)ĮVLJQLILFDQWO\LQFUHDVHG 
 
Paper III 
 
We found downregulation of the cytokine receptors IL7R and CCR7 at birth in the cord 
blood of children later admitted with respiratory syncytial virus disease. No differences 
between mild and severe disease groups were detected for these two genes. There was a 
significant downregulation of TLR4 in patients later admitted with severe disease, 
compared to both control group and mild RSV disease group. Subgroup analysis for age 
did not reveal any significant trends. 
 
The protein results did not statistically confirm the mRNA findings, but the trends 
supported them. 
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6. Discussion 
 
6.1 The use of oxygen during resuscitation 
 
In this study, we found an increase in peroxynitrite (a marker of oxidative stress), 
IUDJPHQWDWLRQRI+$LQIODPPDWRU\FHOODFFXPXODWLRQDQGSURGXFWLRQRI71)ĮDQG,/
in the lungs after exposure to 30 minutes of 100% and not 21 % O2 during resuscitation 
of newborn pigs. This pro-inflammatory response may cause harm to the lung.  
 
Concerns have been raised regarding potential adverse effects of the use of excessive 
oxygen, and many studies have addressed this issue. More recently, evidence has 
accumulated demonstrating that even brief exposure of the lung to hyperoxia is 
associated with increased mortality, decreased cerebral blood flow and oxidative stress to 
the kidneys and heart (194-196). The most recent American Heart Association guidelines 
for neonatal resuscitation emphasize the use of 21 % O2 for resuscitation of term 
newborns (197), and a recent report by Vento et al. support a low oxygen strategy for the 
resuscitation of preterm infants (198) 
 
In the ILCOR guidelines from 2010 it is recommended to begin with air rather than 100% 
oxygen in term or near term infants receiving resuscitation at birth with positive pressure 
ventilation. If despite effective ventilation there is no increase in heart rate or if 
oxygenation, best guided by pulse oximetry, remains unacceptable, a higher 
concentration of oxygen should be considered. According to the Dawson percentiles 
median oxygen saturation one minute after birth is 60-70% and increasing to ± 90% after 
10 min (22). 
In preterm babies of < 32 weeks' gestation, in whom target saturations may not be easily 
reached in air, blended oxygen and air may be given judiciously, again ideally guided by 
pulse oximetry. Both hyperoxemia and hypoxemia should be avoided (199). 
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6.2 Therapeutic potential of N-acetylcysteine (NAC) 
 
In study I treatment with the antioxidant NAC was assosciated with decreased 
peroxynitrite, preservation of HMW HA and decreased cytokine production. Could this 
antioxidant therapy have the potential to limit damage after asphyxia? The possible 
benefit, and the practical approach, of NAC therapy in relations to neonatal resuscitation 
will need extensive study, and is yet unanswered. In addition, with the use of 21 % O2 
resuscitation, there should be decreased need for the use of antioxidant therapy.  
 
6.3 HA as an endogenous mediator of inflammation, and its 
possible effect on TLR4 expression 
 
Our study confirms that HA is an important endogenous mediator of inflammation, as 
shown previously (99). We found a possible effect of HA on TLR4 expression on 
neonatal monocytes. Campo et al. have found a similar decrease in surface expression of 
TLR4 in chondrocytes exposed to HMW HA (200). They have also found that adding 
HA fragments to chondrocytes cultures up-regulated CD44 and TLR4 expression (201), 
and that LMW HA significantly increased TLR4 expression in both unstimulated- and 
LPS-stimulated chondrocytes (200), and we therefore hypothesized that the presence of 
LMW HA would increase the surface expression of TLR4. However, we didn’t find any 
altered expression of TLR4 in the presence of LMW HA. There are limitations of our 
model, and further research in this field is necessary to clarify the role of different 
molecular weight HA neonatal infection. 
 
In addition, the possible biological significance of our measured decrease in TLR4 
expression in the presence of HMW HA is not known. Regulation of inflammation 
involves several immune cells and is fine-tuned in order to enhance the host’s ability to 
withstand pathogens in the circulation. An impaired signaling increases the susceptibility 
of the neonate to infection and invading pathogen. On the other hand, an excessive 
inflammatory response may be harmful and cause organ damage. 
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6.4 Can downregulation of leukocyte cell surface receptors at 
birth predispose to RSV infection in early childhood? 
 
In this study, we hypothesised that differential regulation at birth of cytokine ligands and 
receptors involved in the immune response to RSV predispose to later RSV disease, 
including proteins involved in the regulation of lung pathology by hyaluronan, 
chemoattraction and chemotaxis of myeloid and lymphoid cells, interactions between 
cells of innate and adaptive immune systems, and regulation of lymphocyte responses 
We found downregulation of IL7R and CCR7 in the cord blood of infants later testing 
positive for respiratory syncytial virus. In addition, those with severe disease had 
significant downregulation of TLR4. This may cause an impaired immune response to 
RSV, allowing greater viral replication and tissue damage, and thus more severe disease. 
Further studies are needed in this field.  
 
Interleukin 7 (IL-7) signalling is an important regulator of T-cell survival and 
homeostasis (202). CC-chemokine receptor 7 (CCR7) regulates migration of dendrocytes 
and lymphocytes, both to and within lymph nodes, which is an essential part of 
communication between innate and adaptive immune systems. CCR7 is also involved in 
the development of antigen tolerance (203). 
 
We know that high molecular weight HA protects against the TLR4 induced 
inflammatory response to lipopolysaccharide, in a CD44-dependent manner (204). 
Further that RSV proteins colocalize with CD44, likely leading to critical interactions 
necessary for the formation of filamentous virus particles and syncytium formation (177). 
Low molecular weight HA, produced during inflammatory responses in the lung, 
stimulates cytokine production in macrophages on binding to TLR4 (205). In a mouse 
model, Zhao et al. showed that on intra-tracheal administration of low-molecular weight 
HA, TLR4 knockout resulted in a greater inflammatory response, with increased 
cytokine, chemokine and neutrofil concentrations (206). However, other murine studies 
indicate that TLR4 knockout protects against inflammatory responses or airways 
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hyperreactivity (207;208). HA binding to RHAMM expressed on airway epithelial cells 
cilia stimulates ciliary beating, and thus has a role in airway mucosal defense (100). 
Polymorphisms in TLR4 may predispose children to severe RSV bronchiolitis (160).  
 
Our study did not show any evidence of predisposal to RSV infection caused by altered 
expression of CD44 or RHAMM in cord blood. However, in a future study it would be 
interesting to investigate whether expression of these genes was altered in cord blood of 
infants who later developed asthma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51 
 
6.5 Methodological considerations 
 
Since we have used different models/methods in our studies, I choose to discuss them 
separately. 
 
 
Paper I 
 
Some of the differences between human infants and newborn pigs are different 
biochemical responses, lack of reference values for common functional variables and 
different maturation at birth. The same NIDCAP-care and type of equipment used in 
neonatal intensive care units were being used in the experiments. However attractive, the 
newborn pig model shows large inter-individually variability. Therefore it is important to 
obtain large enough series for satisfactory statistical analyses. The differences between 
the pig model and the clinical situation should be kept in mind when results are 
interpreted. Although the data from our pig models do not necessarily truly mimic human 
conditions, they can hopefully contribute to the complex understanding of the general 
mechanisms of injury following neonatal asphyxia. 
 
The use of anaesthesia is a challenge in animal research, as it will affect the results, 
complicating comparison and interpretation of previous experiments. On the other hand, 
piglets are easily stressed, and pain and anxiety in the experimental animals will also 
affect the results by adrenergic stimulation and not reflect the true resting situation. The 
wellbeing of the animals will always be our first priority. Dose level of anaesthetics for 
research animals have been developed through veterinary practice and from dose levels 
used in humans without considering variations between species (180;209). Most of the 
anaesthetics in the present work are capable of interfering with hemodynamics and 
cerebral blood flow. However, all animals received the same drugs, so the anaesthesia 
should have minor influence in the differences found between the groups. 
 
Another drawback of the current study is that the experiments where the animals were 
given NAC were done separately, and at a later date than the other experiments they were 
compared to. They were therefore not randomized in the same manner. The intervention 
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of giving NAC at the onset of resuscitation is also difficult in a clinical situation. In 
addition, the animals had already undergone fetal to neonatal transition, and were adapted 
to extra-uterine life when exposed to hypoxia. They were sacrificed at short interval from 
the injury, and the long term effects of 100% O2 exposure to the lung, and NAC 
treatment, were not assessed. 
 
Despite these methodological weaknesses, our study can hopefully provide us with 
important understanding of mechanisms by which 100% O2 exposure to the lung causes 
harm, and stimulate further research in the field.  
 
Paper II 
 
We chose this whole blood model in order to study monocytes in their natural habitat. 
However, there are variables present in this model that impede the interpretation of 
results, like the different cell types and proteins in the plasma that bind HA and the 
intermediates generated by HA action.  
 
It is known that HA fragments signal through CD44 as well as TLR2 and TLR4 to 
stimulate inflammatory cells. There is also a sequential action of specific proteins of the 
innate immunity cells which bind and transfer lipopolysaccharide (LPS) to TLR4. In 
addition, a number of molecules are involved in the intracellular signal transduction. To 
understand the mechanisms of the cytokine response in our study, efforts to look into 
other signal transducers and other immune cells are necessary.  
 
HMW HA could be degraded by hyaluronidases in our model. This can explain why both 
HMW- and LMW HA stimulated production of proinflammatory cytokines and MMP9. 
Not knowing whether, and to which extent, the HA was degraded during the incubation 
period is a limitation of our study, along with the number of samples.  
 
In vivo hepatocytes and surrounding connective, vascular and immune cells are important 
sources of cytokines during acute inflammatory response in severe infections (210). 
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Pathophysiological events differ from organ to peripheral blood, and from organ to organ 
(211). Studying the immune response ex vivo can not give us a full understanding of the 
immune response in an organism, but can provide us with useful information and 
stimulate further research. 
 
Paper III 
 
Our gene expression studies are conducted in cord blood, and one must therefore use 
caution in drawing conclusions about the pathogenic processes in pulmonary or 
lymphatic tissue. In addition there is a long time span between the cord blood samples 
and the later RSV infection, but these studies were undertaken to find out if there is any 
gene mediated immune response susceptibility for developing RSV disease when 
exposed to the virus in early childhood. The samples were taken after a stressful 
experience (birth), which evokes an immune response. In addition, it is likely that 
individuals in the control group were also exposed to RSV, but they probably had a mild 
course of disease such as rhinitis, and we believe that the chance of severe RSV disease 
in the control group was low. 
 
Concerning the protein analysis, the contamination with erythrocytes and plasma in our 
samples was a drawback. In order to correct for this, we normalized our target protein 
levels against the level of CD45 in our samples. 
It is also important to be aware that the data produced by a Western blot is typically 
considered to be semi-quantitative. This is because it provides a relative comparison of 
protein levels, but not an absolute measure of quantity.  
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7. Conclusions 
 
 
Compared to 21% O2 resuscitation, resuscitation with 100% O2 for 30 minutes resulted in 
increased fragmentation of HA in the lung of asphyxiated newborn pigs, increased 
peroxynitrite as a measure of oxidative stress, and increased production of TNF-ĮDQG,/-
1 ß.  
 
In study I, antioxidant treatment with NAC prevented the degradation of HA, the 
expression of peroxynitrite and blocked increases in inflammatory cytokines in animals 
exposed to 100% O2 during resuscitation. 
 
The HA content of BAL decreased at the end of asphyxia in study I, and the HA content 
in the serum increased. BAL HA was significantly increased in animals resuscitated with 
100% O2 and this increase was completely inhibited by treatment with NAC. 
 
Our results in study II confirm that hyaluronan affects the neonatal immune response. We 
found a possible down-modulation of Toll-like receptor 4 exerted by high molecular 
weight hyaluronan. More studies are needed to validate this finding and the biological 
significance of these findings requires further clarification. 
 
We found a downregulation of IL7R and CCR7, but not modulation in gene expression of 
the HA receptors/hyaluronan-binding proteins CD44 and RHAMM, in the cord blood of 
infants later (during the first 36 months of life) testing positive for RSV. In addition, 
those with severe disease had significant downregulation of TLR4. 
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8. Future perspectives 
 
 
Our studies raise several questions. It would be interesting repeating the experiments in 
study I with the use of different oxygen concentrations during resuscitation. In addition, 
the use of NAC as a therapeutic agent needs further investigations. Dose-response 
studies, evaluation of appropriate time point for administration (administered to the 
mother during birth, or to the neonate during ongoing resuscitation or afterwards) are 
questions that are still unanswered. It would also be interesting to assess the long term 
effects of 100% O2 exposure to the lung.  
 
We have an ongoing study where we measure serum HA in neonates with sepsis. We aim 
to clarify the significance of HA during neonatal infection, and its role as a mediator of 
inflammation. In these neonates we also study surface expression of TLR4 and TLR2 on 
monocytes, and CD44 on monocytes and lymphocytes. Results will be compared with the 
same parameters in healthy neonates.  
 
To understand the mechanisms of the cytokine response in study II, efforts to look into 
other signal transducers and other immune cells are necessary, and requires further 
research. 
Concerning study III, it would be interesting to measure expression of the relevant genes 
during the RSV infection, and to study polymorphisms of these genes. I question whether 
expression of the genes in our paper are altered in cord blood of infants who later develop 
asthma, and in other lung pathologies/infections. 
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Abstract
Background: Newborn resuscitation with 100% oxygen is associated with oxidative-nitrative stresses and inflammation. The
mechanisms are unclear. Hyaluronan (HA) is fragmented to low molecular weight (LMW) by oxidative-nitrative stresses and
can promote inflammation. We examined the effects of 100% oxygen resuscitation and treatment with the antioxidant, N-
acetylcysteine (NAC), on lung 3-nitrotyrosine (3-NT), LMW HA, inflammation, TNFa and IL1ß in a newborn pig model of
resuscitation.
Methods & Principal Findings: Newborn pigs (n = 40) were subjected to severe asphyxia, followed by 30 min ventilation
with either 21% or 100% oxygen, and were observed for the subsequent 150 minutes in 21% oxygen. One 100% oxygen
group was treated with NAC. Serum, bronchoalveolar lavage (BAL), lung sections, and lung tissue were obtained. Asphyxia
resulted in profound hypoxia, hypercarbia and metabolic acidosis. In controls, HA staining was in airway subepithelial matrix
and no 3-NT staining was seen. At the end of asphyxia, lavage HA decreased, whereas serum HA increased. At 150 minutes
after resuscitation, exposure to 100% oxygen was associated with significantly higher BAL HA, increased 3NT staining, and
increased fragmentation of lung HA. Lung neutrophil and macrophage contents, and serum TNFa and IL1ß were higher in
animals with LMW than those with HMW HA in the lung. Treatment of 100% oxygen animals with NAC blocked nitrative
stress, preserved HMW HA, and decreased inflammation. In vitro, peroxynitrite was able to fragment HA, and macrophages
stimulated with LMW HA increased TNFa and IL1ß expression.
Conclusions & Significance: Compared to 21%, resuscitation with 100% oxygen resulted in increased peroxynitrite,
fragmentation of HA, inflammation, as well as TNFa and IL1ß expression. Antioxidant treatment prevented the expression of
peroxynitrite, the degradation of HA, and also blocked increases in inflammation and inflammatory cytokines. These
findings provide insight into potential mechanisms by which exposure to hyperoxia results in systemic inflammation.
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Introduction
Worldwide, perinatal asphyxia is the single most important
cause of brain injury in the newborn, and has consequences that
are potentially devastating and lifelong [1]. Although the hypoxic-
ischemic insult starts a cascade of events that ultimately may cause
cell death and damage to the central nervous system, a systemic
inflammatory response that also affects other organ systems
including the heart, lungs, liver and kidneys has been described
[2]. Despite earlier reports (dating back to 1897) of similar efficacy
of either 100% oxygen (O2) or room air (21% O2), which
remained largely ignored, neonatal resuscitation, since its incep-
tion, has been carried out using 100% O2 [3]. More recently,
evidence has accumulated demonstrating that even brief exposure
of the lung to hyperoxia is associated with increased mortality,
decreased cerebral blood flow and oxidative stress to the kidneys
and heart [4,5,6]. Indeed, the most recent guidelines for neonatal
resuscitation emphasize the use of 21% O2 for resuscitation of
term newborns [7], and recent reports support a low oxygen
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strategy for the resuscitation of preterm infants [8,9]. Examination
of the effects of 100% versus 21% O2 resuscitation in animal
models has been studied most extensively in the pig [10,11].
Indeed, 100% O2 resuscitation is associated with increased
inflammatory markers, decreased anti-oxidant capacity, increased
oxidative damage to DNA and proteins, and increased evidence of
structural damage to the brain [12,13]. These data suggest that
exposure to hyperoxia results in changes that stimulate a systemic
inflammatory response that affects multiple organ systems. One
potential mechanism could be the formation of reactive oxygen
and nitrogen free radicals following exposure to 100% O2 [14,15].
Three groups of ‘reactive species’ have been described, namely
reactive oxygen species (ROS), which are partially reduced forms
of oxygen (for example, superoxide), reactive nitrogen species
(RNS), which are partially reduced nitrogen species (for example,
nitric oxide (NO)), and the combination of the two, reactive
oxygen and nitrogen species (RONS), which are highly reactive
and damaging species (for example, peroxynitrite) [14]. Under
physiological conditions, ROS and RNS are produced at low
fluxes, with minimal production of RONS, and in a localized
manner that result in intracellular signaling [14]. However, with
increased fluxes of ROS and RNS, the combination of NO with
superoxide to form peroxynitrite occurs at a nearly diffusion
limited rate, with a dramatic rise in the production of RONS [16].
In contrast to discrete modifications resulting in cellular signaling,
the chemical reactivity of RONS results in non-specific modifica-
tions that result in cellular injury and death. Importantly, however,
the generation of RONS not only generates toxic species but also
reduces the availability of ROS and RNS for signaling functions.
Therefore the interaction of ROS and RNS is a two-edged sword
that produces both a gain of toxicity and a loss of physiological
function. The mechanisms of tissue damage with RONS include
disruption of cell membranes (lipid peroxidation), mitochondrial
injury, modifications of nucleic acids and DNA scission, activation
or inactivation of growth factors, apoptosis and the generation of
multiple reactive species that cause further damage [15,17]. In
particular, peroxynitrite causes the nitration of tyrosine residues at
the 3-position to produce 3-nitrotyrosine (3-NT) [18]. Nitration
has been shown to result in functional alterations of modified
proteins, and has been demonstrated in a wide variety of human
diseases and in animal models of tissue injury [19,20,21].
Hyaluronan (HA), a glycosaminoglycan made up of repeating
disaccharide units of glucuronic acid and N-acetyl glucosamine, is
an early and important mediator of inflammation [22]. An
increased recovery of HA in bronchoalveolar lavage (BAL) has
been found in various disease states such as sarcoidosis [23],
occupational disorders [24] and Acute Respiratory Distress
Syndrome (ARDS) [25], and after acute lung injury as with
intratracheal bleomycin instillation in rodents [26,27,28]. Further,
the increased recovery of HA temporally correlates with an influx
of inflammatory cells [29]. HA regulation of inflammation is both
dose- and molecular size-dependent. The molecular weight of HA
in BAL from injured animals is 200–700 kDa [30], whereas in situ
lung HA is considerably larger at .106 Dalton. Low molecular
weight HA (LMW HA, , ,500–700 kDa), and HA oligosaccha-
rides (6-30-mer lengths) increase gene expression of proinflamma-
tory chemokines and iNOS in macrophage cell lines as well as in
alveolar macrophages from injured rats [31,32]. The changes in
localization, content and size of HA during neonatal asphyxia and
resuscitation have not been studied previously.
Since superoxide and peroxynitrite cause chemical fragmenta-
tion of HA [33,34,35,36,37] and LMW HA can stimulate the
inflammatory process [29,38,39], we hypothesized that exposure
to 100% O2 during neonatal resuscitation would result in
increased peroxynitrite production, fragmentation of HA and an
increased inflammatory response. Using a neonatal pig asphyxia
model, we examined the early local effects of resuscitation with
100% O2 on the lung, and the associated systemic inflammatory
response. We here report that exposure of the lung to 100% O2
was associated with increased 3-NT and decreased HA staining,
and fragmentation of HA in the lung. Both TNFa and IL1ß were
increased in 100% O2 exposed animals, and, compared to those
with HMW HA content, animals with LMW HA content in the
lung had significantly more neutrophils and macrophages, as well
as higher plasma concentrations of TNFa and IL1ß. Treatment of
100% O2-exposed animals with NAC decreased 3NT staining,
preserved HMW HA and decreased inflammation and cytokine
expression. Furthermore, in vitro studies showed that peroxynitrite,
and not nitric oxide, fragments HA, and that oligomeric HA
stimulates TNFa and IL1ß expression, in a macrophage cell line.
Results
Neonatal Pig Resuscitation Model
There were no significant differences across groups with respect
to body weight, age, gender and hemoglobin. Baseline hemody-
namic and pulmonary parameters, including blood gases, were
also not significantly different between the groups (Table 1). The
experimental protocol followed, shown in Figure 1, involved the
induction of asphyxia by the administration of 8% O2. As
published by us previously [11], asphyxiated pigs showed profound
respiratory/metabolic acidosis, hypoxemia, and hypotension, with
similar degrees of compromise at the end of the asphyxia period in
both the 21% and 100% O2 resuscitation groups (Table 2). As
expected, the PaO2 of animals at the end of resuscitation was
significantly higher in animals resuscitated in 100% O2 than those
resuscitated in 21% O2 (49.1621.1 kPa vs. 13.061.9 kPa,
P,0.001).
Changes in 3-NT and HA Staining with 100% O2
Resuscitation and NAC Treatment
Formalin-fixed, paraffin-embedded sections of inflated lungs
were processed for dual label immunofluorescence using an
antibody specific for 3-NT to localize peroxynitrite (red), and a
biotinylated HA-binding probe to localize HA (green), with DAPI
to label nuclei (blue) as described in Materials and Methods.
Images were obtained from both the distal parenchyma and the
proximal airway. Control animals had abundant staining for HA
in the sub-epithelial matrix around bronchiolar smooth muscle
and on the endothelium of blood vessels, with less evident staining
in the distal parenchyma and alveoli (Fig. 2). Animals examined
150 minutes after the 30-minutes exposure to 21% O2 resuscita-
tion had HA staining that was not distinguishable from control
animals, and had no staining for 3-NT (Fig. 2). However, 150
minutes after the 30-minute exposure to 100% O2, little to no HA
staining and a significant increase in 3-NT staining was observed
throughout the lung (Fig. 2). Interestingly, animals resuscitated
with 100% O2 and treated with NAC had substantially less 3-NT
staining, and HA staining that was similar to control animals.
These data demonstrate that 3-NT is only evident after hyperoxia
exposure and is associated with decreased HA in the lung, and that
treatment with the antioxidant decreases 3-NT and preserves HA
staining.
Changes in BAL and Serum HA with 100% O2
Resuscitation and NAC Treatment
We next determined the content of HA in both BAL and serum
under the various experimental conditions. Data were compared
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as a percent of control animals. BAL HA content decreased and
serum HA increased with asphyxia (Fig. 3A and B). At 150
minutes after the end of the resuscitation period, animals
resuscitated in 100% O2 had significantly higher BAL HA
concentrations than animals resuscitated in 21% O2 (Fig. 3A).
Animals exposed to 100% O2 and treated with NAC did not show
this later increase in BAL HA (Fig. 3A). While serum HA did not
show a significant rise at 150 minutes in animals exposed to 100%
O2, treatment with NAC decreased serum HA concentration
(Fig. 3B). In order to determine the balance of HA synthesis and
enzymatic degradation of HA, we determined the lung mRNA
contents for the three HA synthase genes (has1, 2 and 3) as well as
two hyaluronidases (hyal1 and hyal2). No significant differences
were noted in has1 and has3 expression under any condition (data
not shown). The expression of has2 was significantly decreased
(Fig. 3C), and the expression of hyal1 and hyal2 was significantly
increased in animals treated with NAC (Fig. 3D and E), suggesting
that the net result would be less HA with anti-oxidant treatment.
Pig lungs were then processed to determine the molecular size of
HA as described in Materials and Methods (Fig. 4). Control
animals had largely HMW HA, whereas pigs at the end of the
asphyxia period had an intermediate size HA. Interestingly, 21%
O2 exposed animals demonstrated HMW HA suggesting in-
creased synthesis, whereas those exposed to 100% O2 showed
almost completely degraded HA (Fig. 4). Interestingly, 100% O2
exposed animals treated with NAC showed substantial preserva-
tion of HMW HA (Fig. 4). Given the decreased has2 and increased
hyal1/2 expression (Fig. 3), it is most likely that the decreased
oxidative and nitrative stress noted with NAC treatment (Fig. 2)
prevented the fragmentation of HA. We next determined the
proportion of animals with LMW HA in the lung in the various
groups studied (Table 3). Interestingly, control animals had almost
exclusively HMW HA in the lung, whereas pigs at the end of
asphyxia had exclusively LMW HA. Animals resuscitated in 21%
O2 returned to HMW HA whereas those resuscitated in 100% O2
continued to have LMW HA in the lung. Animals treated with
NAC had mostly HMW HA in their lungs. Collectively, these data
Table 1. All pigs were comparable at baseline.
Characteristic Control (n =8) Post-asphyxia (n =9)
21% O2 Resuscitation
(n =8)
100% O2
Resuscitation (n =8)
100% O2+ NAC
Resuscitation (n=7)
Weight (g) 15126189 15856191 16756229 15776274 13096145
Heart rate (bpm) 149616 140613 157647 147619 161620
Mean arterial pressure (mmHg) 55617 60614 48613 50610 4666
Arterial pH 7.4860.09 7.4460.06 7.4760.05 7.4560.10 7.460.1
Arterial pCO2 (kPa) 4.960.9 5.360.6 5.660.6 4.860.8 3.560.4
Arterial pO2 (kPa) 13.562.8 13.461.9 12.561.8 14.362.2 11.362.4
Base Excess (mmol/L) 3.062.8 2.465.0 5.762.3 0.464.5 7.463.2
ETCO2 (kPa) 4.160.9 4.660.5 4.760.6 4.060.8 5.460.7
Lactate (mmol/L) 1.960.5 2.060.5 2.360.8 2.260.7 4.462.9
Hemoglobin (g) 6.761.6 6.961.0 6.361.5 7.060.9 7.461.2
Blood Glucose (mmol/L) 6.061.5 5.861.2 6.360.9 5.561.0 3.661.1
doi:10.1371/journal.pone.0038839.t001
Figure 1. Experimental protocol. After anesthesia, ventilation, and instrumentation followed by 60 min of stabilization, pigs were subjected to
asphyxia, followed by either 21% or 100% O2 resuscitation for 30 min, and then observed for a further 150 min after resuscitation when all animals
were maintained in 21% O2. A separate group of animals resuscitated for 30 minutes with 100% O2 were treated with the antioxidant N-
acetylcysteine (NAC) from the time of the start of resuscitation until the end of the experiment. Samples were obtained from five groups: Control
animals were euthanized after undergoing surgical preparation and anesthesia but prior to asphyxia; the asphyxia group was harvested at the end of
asphyxia prior to any resuscitation; and three groups of animals resuscitated with either 21% or 100% O2 or with 100% O2 and given NAC were
harvested at 150 min after respective resuscitation strategies.
doi:10.1371/journal.pone.0038839.g001
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suggest that exposure to 100% O2 was associated with an elevated
content of LMW HA, and that antioxidant treatment was
associated with a shift to HMW HA.
Increased Lung Neutrophil and Macrophage Contents in
Animals with LMW HA are Inhibited by Antioxidant
Treatment
We next determined myeloperoxidase (MPO) and N-acetyl
glucosaminiadase (NAG) activities of lung as measures of
neutrophil and macrophage contents respectively (Fig. 5). Data
were segregated according to the molecular size of lung HA and
plotted as interquartile ranges. Animals with LMW HA had
significantly higher MPO and NAG activities confirming an
increased accumulation of neutrophils and macrophages in
animals that had LMW HA in the lung (Fig. 5A and B). Animals
exposed to 100% O2 and treated with NAC had significantly lower
MPO and NAG activities as compared to animals exposed to
100% O2 alone (Fig. 5C and D). These data suggest that
antioxidant treatment was associated with decreased inflammation
after 100% O2 resuscitation.
Since inflammation is often associated with edema, we also
determined whether any differences in water content existed
between the various groups. No significant differences in water
content were found in any group (data not shown).
Increased Serum TNFa and IL1ß Concentrations in
Animals with LMW HA are Inhibited by Antioxidant
Treatment
Serum TNFa and IL1ß contents were determined using
commercially available ELISA kits. Data were again segregated
according to the molecular size of HA in the lung and presented as
interquartile ranges. Animals with LMW HA had significantly
higher TNFa and IL1ß concentrations (Fig. 6A and B). Treatment
of 100% O2 exposed animals with NAC resulted in significantly
lower TNFa and IL1ß concentrations (Fig. 6C and D). Collec-
tively, these data suggest that hyperoxia exposure to the lung
results in increased serum TNFa and IL1ß concentrations in
association with LMW HA, and that NAC treatment is associated
with lower cytokine levels.
Peroxynitrite, but Not Nitric Oxide, Fragments HMW HA
to LMW HA In vitro
In order to confirm the specificity of the fragmentation of HA
by peroxynitrite, we exposed HMWHA (HealonTM, 16106 Da) to
100 mM 3-morpholinosydnonimine (SIN-1), a compound that
spontaneously decomposes to release NO and superoxide to
generate peroxynitrite at pH 7.4 (Fig. 7). Exposure of HMW HA
to SIN-1 resulted in degradation to LMW HA (300–500 kDa).
Exposure to SIN-1 in the presence of superoxide dismutase (SOD)
partially protected this degradation, whereas exposure to PA-
PANOATE, a pure NO donor, did not degrade HealonTM. In
addition, treatment of HMW HA with either Streptomyces
hyaluronidase at 60uC for 2 hours or sonication for 2 minutes
resulted in formation of LMW HA. These data show that
superoxide and peroxynitrite, and not nitric oxide itself, fragment
HMW to LMW HA.
Oligomeric HA Stimulates TNFa and IL1ß Expression in
Macrophages In vitro
In order to determine the effects of LMW HA on TNFa and
IL1ß expression, we stimulated the murine macrophage cell line
RAW264.7 with a six-sugar length HA oligosaccharide (HA6) that
was confirmed to be free of endotoxin, nucleic acid and protein.
HA6 (10 mg/ml) significantly stimulated the production of TNFa
and IL1ß (Fig. 8). Collectively, these data support the hypothesis
that the presence of peroxynitrite fragments HMW to LMW HA
and that LMW HA stimulates the production of TNFa and IL1ß
in macrophages.
Discussion
In this study, we demonstrate that exposure to 100% and not
21% O2 during resuscitation is associated with increased
peroxynitrite and LMW HA content in the lung. Interestingly,
increased inflammatory cell accumulation and elaboration of
TNFa and IL1ß was noted in animals that had LMW HA in the
lung. Treatment with the antioxidant, N-acetylcysteine (NAC),
was associated with decreased peroxynitrite, preserved HMW HA
and less inflammatory cell accumulation and cytokine expression.
Further, in cultured murine macrophages, peroxynitrite was able
to degrade HMW to LMW HA, and oligomeric HA was able to
stimulate TNFa and IL1ß production. These data suggest
potential mechanisms by which oxygen exposure during resusci-
tation could fragment HMW to LMW HA and stimulate an
inflammatory response.
The use of oxygen in human resuscitation was attempted within 5
years of its discovery in 1772 [3]. Despite later descriptions of the
possibility of adequate resuscitation with room air, and pre-clinical
studies that demonstrated the potential harmful effects of oxygen
radicals, the practice of 100% O2 resuscitation continued. The
Resair2 study, published in 1998 [40], demonstrated that newborn
infants could be resuscitated effectively with 21%O2, and resulted in
a faster time to first breath and cry. Further, 21% O2 resuscitation
was not associated with adverse effects in neurodevelopmental
Table 2. All pigs were equally asphyxiated.
Characteristic Control (n =8)
Post-Asphyxia
(n=9)
21% O2 Resuscitation
(n =8)
100% O2 Rususcitation
(n =8)
100% O2+NAC Rususcitation
(n =7)
Time to asphyxia (min) – 55619 63642 58625 70624
Heart rate (bpm) – 132633 143625 160620 130625
Mean arterial pressure (mmHg)– 1765 1563 1964 2563.2
Arterial pH – 6.9160.06 6.9260.12 6.960.09 7.060.1
Arterial pCO2 (kPa) – 9.060.3 8.961.2 8.961.3 8.161.3
Arterial pO2 (kPa) – 4.960.4 4.660.4 4.660.4 4.260.3
Lactate (mmol/L) – 9.463.9 11.460.9 11.563.0 9.762.1
doi:10.1371/journal.pone.0038839.t002
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outcome [41]. Multiple other clinical trials have now been
conducted that demonstrate that 21% O2 resuscitation of term
infants is as efficient as 100% O2 and is associated with decreased
mortality [4]. However, the mechanisms by which 100% O2
exposure to the lung causes harm have not been fully examined.
The best-studied model of neonatal resuscitation to date is the
newborn pig [10]. The maturation of the pig brain is similar to
that of a term human infant, and the newborn pig size allows the
use of intensive care equipment used for babies. A number of
studies have demonstrated increased accumulation of inflamma-
tory cells in the lung, elevated lung inflammatory markers, and
decreased lung compliance with 100% O2 exposure during
resuscitation [42,43]. Additionally, this level of O2 exposure is
associated with decreased anti-oxidant capacity, increased oxida-
tive damage to DNA and proteins, increased apoptosis and
evidence of structural damage to the brain [13]. At the same time,
it is important to note the limitations of the newborn pig model
used in these studies. While useful as a controlled experimental
model to determine the mechanisms involved, it does not exactly
reproduce the clinical setting. For example, there is no fetal to
neonatal transition, the animals receive a long exposure (30
minutes) to 100% O2, and the animals are sacrificed at very short
intervals from the injury.
Multiple studies in animal models indicate that superoxide and
nitric oxide (NO) participate in hyperoxic lung injury [44,45,46].
High levels of NO, such as those present with inflammation, react
with superoxide to yield higher oxides of nitrogen, in particular
peroxynitrite [47]. Peroxynitrite, an oxidant capable of damaging
alveolar epithelium and pulmonary surfactant [48,49], reacts with
proteins to form 3-nitrotyrosine, thereby altering protein function
[50,51,52]. Indeed, nitration of myosin light chain 2 in the hearts
of asphyxiated pigs is associated with cardiac dysfunction [53]. It is
important to remember that exposure to hyperoxia provokes a
systemic hyperoxic challenge with effects on multiple organ
systems. Indeed, the formation of oxygen and nitrogen free
radicals influences the development of pulmonary hypertension
[54]. In addition, N-acetyl-glucosaminidase, the macrophage
marker used in the current studies, is also found in the liver and
kidneys, and is significantly increased in babies with asphyxia that
have been resuscitated with 100% O2 [6]. Cheung et al. have
examined the effects of antioxidant treatment in this model of
resuscitation. Treatment with NAC, which blocks the production
of superoxide and peroxynitrite, results in decreased oxidative
stress, improved hemodynamics and tissue perfusion, and
decreased platelet aggregation after hypoxia-reoxygenation
[55,56,57,58,59,60]. However, the mechanisms by which oxida-
tive and nitrative stresses promote inflammation have not been
fully defined.
Hyaluronan (HA) is an early and important mediator of
inflammation [22,39]. HA regulation of inflammation is both
dose- and molecular size-dependent. HA, at doses of 1 mg/ml or
greater, inhibits inflammatory cell chemotaxis [61], phagocytosis
and respiratory burst activity [62], as well as elastase release [63].
HA also acts as an anti-inflammatory and anti-fibrotic agent in
rheumatoid and osteoarthritis [64], and in repair of tympanic
membrane perforations [65]. In addition, HA accelerates
cutaneous wound healing [66] and reduces adhesion formation
after intra-abdominal surgery [67]. On the other hand, at lower
concentrations and at lower molecular weights, HA promotes
monocyte maturation into macrophages as measured by
production of insulin-like growth factor-1 [68], and HA is
greatly increased during inflammatory conditions such as
myocardial infarction [69], arthritis [70] and during transplant
rejection [71]. Furthermore, removal of HA with early treatment
of myocardial infarction with hyaluronidase results in reduced
myocardial fibrosis and infarct size [72]. We previously
demonstrated that alveolar macrophages from bleomycin-injured
animals are more motile than those from control animals and
that HA-binding peptide is able to completely inhibit this
increased motility [29]. Further, systemic administration of HA-
binding peptide to animals prior to injury resulted in decreased
macrophage accumulation and fibrosis [29]. These data suggest
that HA is upstream of and critical for the inflammatory
response to lung injury. HMW HA can be fragmented to LMW
HA chemically by exposure to superoxide and peroxynitrite
[35,73]. Our findings that treatment with NAC results in
decreased 3-NT and preservation of HMW HA, and that the
balance of HA synthetic and degrading enzymes favors HA
degradation, strongly suggests that HA fragmentation is largely
due to chemical rather than enzymatic processes. Thus,
treatment with NAC shifts the lung HA environment from a
pro-inflammatory to an anti-inflammatory predominance. This is
confirmed by our findings that NAC treatment was associated
with decreased inflammation and cytokine elaboration.
We also showed that superoxide and peroxynitrite generation
by SIN-1 resulted in fragmentation of HMW HA in vitro.
Importantly, however, a pure nitric oxide donor failed to fragment
HA, suggesting that it is the combination of superoxide and nitric
oxide that is relevant for the observation. Indeed, administration of
high concentrations of NO in conjunction with hyperoxia is
harmful to the lung, whereas lower concentrations are beneficial
[74]. In addition, studies in extracellular superoxide dismutase
(EC-SOD) knockout mice demonstrate that this anti-oxidant
enzyme prevents the effects of superoxide and peroxynitrite on
fragmentation of HA and limits inflammatory responses to lung
injury [75].
The stimulation of cytokine production by HA has been
demonstrated previously. However, the mechanisms by which this
occurs are unclear. It has been postulated that CD44, a type 1
receptor for HA, complexes with TLR4 to mediate signals that
activate the innate immune system [22,39,76,77]. Whether this
complex also regulates the production of TNFa and IL1ß after
100% O2 resuscitation and whether other cytokines are also
affected in a similar manner have yet to be investigated.
In summary, we here demonstrate that resuscitation of neonatal
pigs with 100% O2 is associated with increased peroxynitrite,
fragmentation of HA and increased TNFa and IL1ß production.
Treatment with the antioxidant NAC is associated with decreased
peroxynitrite, preservation of HMW HA and decreased cytokine
production. The current findings provide proof-of-concept that
Figure 2. Dual immunostaining for 3-nitrotyrosine and HA. Formalin-fixed, paraffin-embedded sections of inflated lungs were processed for
dual label immunofluorescence using an antibody specific for 3-NT to localize peroxynitrite (red), and a biotinylated HA-binding probe to localize HA
(green), with DAPI to label nuclei (blue). Control animals had abundant staining for HA in the sub-epithelial matrix around bronchiolar smooth muscle
and on the endothelium of blood vessels, with less evident staining in the distal parenchyma and alveoli. At the end of asphyxia, there appeared to
be a slight, but generalized decrease in HA staining in both the proximal airway as well as the distal parenchyma. Animals examined 150 minutes
after 21% O2 resuscitation had HA staining that was not distinguishable from control animals, and had no staining for 3-NT. However, 150 minutes
after 100% O2 exposure, little to no HA staining and an increase in 3-NT staining was observed throughout the lung. Animals resuscitated with 100%
O2 and given NAC had little 3-NT staining and had HA staining similar to that of animals resuscitated with 21% O2.
doi:10.1371/journal.pone.0038839.g002
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antioxidant therapy has the potential to limit damage in situations
where 100% O2 is used during resuscitation. However, the level of
O2 exposure that results in the observations made in this report are
yet to be defined in the newborn pig model, and the efficacy of
antioxidant therapy during human resuscitation will need exten-
sive study. Indeed, with the use of 21% O2 resuscitation for term
infants, there should be decreased need for the use of antioxidant
therapy. The model that we have developed for the mechanisms
explored by the current studies is shown in Figure 9. We speculate
that limiting the use of 100% O2 during resuscitation, or blockade
of the effects of LMW HA, for example by using HA-binding
peptide, will limit the systemic inflammatory response and
potentially decrease end organ damage in neonates suffering
asphyxia.
Materials and Methods
Ethics Statement
The Department of Comparative Medicine, Oslo University
Hospital (Protocol # 37/06) and the University of Texas
Southwestern Medical Center Institutional Animal Care and
Utilization Committee (Protocol # 2011-0002) approved the
experimental protocol. Animals were cared for and handled in
accordance with the Norwegian Council for Animal Research, as
well as European and NIH Guidelines for Use of Experimental
Animals, by certified FELASA (Federation of European Labo-
ratory Animals Science Association) and UT Southwestern
researchers.
Surgical Preparation and Anesthesia
Forty newborn Noroc (LYxLD) pigs, 12–36 h of age, Hb $5 g/
dL, and in good general condition were included in the study. The
pigs were anesthetized, orally intubated, ventilated, and surgically
prepared as described by Andresen et al. [78]. Briefly, after
anesthesia induced by Sevofluran 5% (Sevorane, Abbott), intra-
venous pentobarbital and fentanyl were administered, and
anesthesia was continued with fentanyl and midazolam infusions.
A continuous intravenous infusion of 0.7% saline and 1.25%
glucose was given throughout the experiment. A tracheotomy was
performed and animals were ventilated using a pressure-controlled
ventilator to achieve normal ventilation (PaCO2 4.5–6.0 kPa, O2
saturations .90% & tidal volume 8–15 ml/kg). The left femoral
artery and vein were cannulated with polyethylene catheters.
Rectal temperature was maintained between 38.5 and 40uC with a
heating blanket and radiant heating lamp.
Experimental Protocol
After 60 min of stabilization, the pigs were subjected to global
hypoxia, followed by either 21% or 100% O2 resuscitation for
30 min, and then observed for a further 150 min after resuscita-
tion when all pigs were maintained in 21% O2. In separate
experiments, as described previously [59,60], an additional group
of animals exposed to 30 minutes of 100% O2 resuscitation were
treated with a bolus of 150 mg/kg N-acetylcysteine (NAC) starting
at the onset of 100% O2 resuscitation followed by a 20 mg/kg/h
infusion for the duration of the experiment. Samples were
obtained from five groups: Control animals were euthanized after
Figure 3. Hyaluronan content in bronchoalveolar lavage and serum, and expression of enzymes regulating hyaluronan synthesis
and degradation. HA content was determined in BAL (A) and in serum (B). At the end of asphyxia, the HA content of BAL decreased and that in the
serum increased. Resuscitation with 21% O2 did not increase HA either in the BAL or in the serum. However, BAL HA was significantly increased in
animals resuscitated with 100% O2, and this increase was completely inhibited by treatment with NAC (A). The changes in hyaluronan synthase 1
(has1), has2 and has3, as well as hyaluronidase 1 (hyal1) and 2 (hyal2) were determined using quantitative RT-PCR. There were no changes in has1 and
has 3 expression (data not shown). Expression of has2 (C) showed a trend to increased expression after asphyxia and 21% O2 resuscitation. However,
treatment with NAC significantly inhibited has2 expression compared to 100% O2 resuscitation alone (C). The expression of hyal1 (D) and hyal2 (E)
remained unchanged except that 100% O2 exposed animals treated with NAC showed significantly increased expression of both hyaluronidases.
doi:10.1371/journal.pone.0038839.g003
Figure 4. HA size determination. HA size was determined in lung tissue and two representative samples per group are shown in this gel. Control
animals had HMW HA and asphyxia was associated with some degradation of HA. Resuscitation with 21% O2 was associated with HMW HA where as
resuscitation with 100% O2 showed marked degradation of HA. Interestingly, treatment of 100% O2 resuscitated animals with NAC was associated
with a preservation of HMW HA.
doi:10.1371/journal.pone.0038839.g004
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undergoing surgical preparation and anesthesia but prior to
asphyxia; the post asphyxia group was harvested at the end of
asphyxia prior to any resuscitation; and three groups of animals
were harvested at 150 minutes after the 30 minute exposure to
either 21% O2 resuscitation, 100% O2 resuscitation, or 100% O2
resuscitation with NAC treatment.
For asphyxiated groups, hypoxemia was achieved by ventilation
with a gas mixture of 8% O2 in N2 until either mean arterial blood
pressure decreased to 15 mm Hg or base excess (BE) reached -
20 mM/L.CO2was added during hypoxemia aiming at a PaCO2of
8.0–9.5 kPa, to imitate perinatal asphyxia. Before resuscitation,
hypoxic pigs were divided into experimental groups. Resuscitation
was performed for 30 min with 21% or 100% O2. In separate
experiments, a 100%O2 group was also treated with NAC from the
start of resuscitation. After the initial 30 minutes of resuscitation, the
pigs all received 21%O2, were maintained in normocapnia (PaCO2
4.5–5.5 kPa), andwere observed for a further 150 min. Although no
animals died during the experiments, two animals observed for 150
minutes following resuscitation (one in the 21%O2 group and one in
the 100%O2 group) needed short intervals of bag&mask ventilation
during this observation period. Three animals that required
vasoactive drugs during the studies were excluded from the
experimental analysis. At the end of each observation time, the
animals were given an overdose of pentobarbital (150 mg/kg IV).
Bronchoalveolar lavage and plasma samples were obtained, and
tissues were quickly removed, snap frozen in liquid nitrogen, and
stored at -70uC until subsequent analysis.
Antibodies & Other Reagents
Polyclonal anti-3-nitrotyrosine antibody was obtained from Cell
Signaling Technology (Danvers, MA). Biotinylated HA-Binding
Protein (bHABP, Seikagaku Corporation, Tokyo, Japan), a probe
that binds all forms of HA six saccharide units or greater, is the
biotinylated HA-binding region of aggrecan extracted from nasal
bovine cartilage as described by Ripellino et al. [79]. Horseradish
peroxidase-conjugated goat anti-rabbit IgG was purchased from
Zymed Laboratories (San Francisco, CA). Healon is a pure HMW
HAused for ophthalmologic surgery.HA6, a six saccharideHA,was
the kind gift of Seikagaku Corporation, and was verified to be free of
endotoxin, protein and nucleic acid. All other reagents were
purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise
noted.
Immunostaining for 3-nitrotyrosine and HA
Indirect dual immunofluorescence for 3-NT and HA was
performed on 5 mm paraffin-embedded sections. After paraffin
removal and rehydration, endogenous fluorescence was blocked
with 0.1% sodium borohydride for 10 minutes followed by
incubation with fresh 1M glycine in PBS for 1 hour. Nonspecific
binding was blocked by incubation with 100% goat serum for 60
minutes at 4uC. Sections were then incubated with 3-NT antibody
(1:500 dilution) overnight at 4uC. Incubations without primary
antibody or with pre-immune rabbit IgG were used as negative
controls. After washing in PBS with 0.02% Na azide, HA was
localized by incubating sections overnight with the biotinylated HA
binding region of the aggrecan (bHABP 1:200 dilution; Seikagaku
Corporation, Tokyo, Japan). A solution of preincubated HA:b-
HABP 3:1 was used as a negative control. Texas Red-conjugated
goat anti-rabbit IgG and FITC-conjugated streptavidin (each
1:5,000 dilution) were used as secondary probes, exposed for 3
hours, and DAPI was added to localize nuclei. The slides were then
washed and mounted with Fluoromount-G (Southern Biotechnol-
ogy, Birmingham, AL). Labeled sections were visualized using an
inverted Nikon TE 100 microscope. Simultaneous wavelength
scanning allowed superimposition of fluorescent labeling with FITC
and Texas red fluorophores at wavelengths of 488 and 568 nm,
respectively. Overlays were accomplished using Metamorph soft-
ware (Universal Imaging, Downingtown, PA).
ELISA-Like Assay for Hyaluronic Acid (HA)
BAL sampleswere assayed forHAcontent by anELISA-like assay
as previously described [29]. This ELISA measures the competition
of HA present in the sample verses HA coated on a 96-well plate for
binding to a biotinylated HA-binding protein (bHABP Seikagaku,
Japan). Briefly, 60 ml of sample or Healon standard (Pharmacia,
Sweden) were loaded onto non-fat dry milk (NFDM)-blocked
Covalink-NH 96-Microwell plates (Nunc, Fisher Corp.) after
overnight protease digestion. After addition of 60 ml bHABP to
each well and incubation at 37uC for 1 hour, 100 ml of the sample-
bHABP incubation solution were transferred to a HA-coated
Covalink-plate and incubated for 1 hour at 37uC to allow to
competitive binding (0.2 mg/ml HA, ICN Inc.). HA-binding was
detected by an avidin-biotin complex (ABC) reagent (Vectastain)
and o-phenylenediamine (Sigma). The change in absorbance at
450 nm after a 15-minute incubation was measured.
Tissue Water Content and Determination of HA Size
Wet and dry weights of lung tissues were taken before and after
lyophilization, respectively. Tissue water content was calculated by
subtracting dry and wet weight ratio from 1. Lyophilized tissues
were digested in 100 mM ammonium acetate with 0.0005%
phenol red (pH 7.0) containing 0.25 mg/mL proteinase-K
(Roche, Indianapolis, IN) for 4 h at 60uC with occasional
vortexing. Proteinase-K was inactivated by boiling, and undigested
tissues were pelleted by centrifugation at 160006g. An aliquot of
100 ml supernatant equal to 5 mg dry weight of digested lung was
processed for HA molecular weight determination as described
elsewhere with minor modifications [80]. To remove DNA and
RNA from tissue extracts, tissues were treated with 3 ml of DNase
(Ambion, Austin, Texas) and 3 ml of RNaseA (1.28 mg/ml,
Roche, Indianapolis, IN), respectively, for 5 h at 37uC. Samples
were boiled to inactivate enzymes and HA was precipitated in
80% ethanol at220uC overnight. Following centrifugation, pellets
were resuspended in 16 ml of Tris-Na Acetate - EDTA, pH.7.9
and 4 ml loading buffer (0.2% Bromophenol Blue, 1 ml TAE
buffer and 8.5 ml glycerol). Samples were run on a 1% agarose gel
(Seakem HGT Cambrex, Rockland, ME) made in TAE buffer.
Table 3. Proportions of pigs with LMW HA after asphyxia and
21% vs. 100% O2 resuscitation.
Groups HMW (n) LMW (n) % LMW
Control (n = 8) 7 1 14%
Post-Asphyxia (n = 9) 0 9 100%
21% O2 Resuscitation (n = 8) 6 2 25%
100% O2 Resuscitation (n = 8) 3 5 63%
100% O2+ NAC Resuscitation
(n = 7)
5 2 29%
The majority of control animals had HMW HA in the lung. At end of asphyxia,
pigs had exclusively LMW HA, which recovered to a preponderance of HMW HA
with 21% O2 resuscitation. Exposure to 100% O2 resuscitation was associated
with a change from HMW to LMW HA. Treatment with NAC showed a
protection of HMW HA. These data show that asphyxia and exposure to 100%
O2 is associated with fragmentation of HA in the lung and that antioxidant
treatment protects against this degradation in vivo.
doi:10.1371/journal.pone.0038839.t003
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The gel was pre-run for ,2 h at 80V prior to loading samples and
HA size standards (Hyalose, Oklahoma City, OK). After
electrophoresis at 80 V, the gel was equilibrated in water for
48 h followed by incubation in 30% ethanol for 30 min. The gel
was then stained with 0.01 mg/ml Stains-All solution (Sigma, St
Louis, MO) in 30% ethanol overnight in the dark. Gel was
destained in water until bands were visualized before scanning.
Figure 5. Lung myeloperoxidase and N-acetylglucosaminidase activities as measures of neutrophil and macrophage contents
respectively.Macrophage content was determined by NAG activity and neutrophil content was determined by MPO activity as described previously
[82] and in Materials and Methods. Data were segregated according to the molecular size of HA found in the lung and plotted as box and whisker
plots with outliers shown as additional dots. Both NAG (A) and MPO (B) activities were significantly higher in animals that had LMW HA. Newborn pigs
resuscitated with 100% O2 and treated with NAC had significantly lower NAG (C) and MPO (D) activities than those without NAC treatment,
suggesting that antioxidant treatment decreases the inflammatory response to resuscitation with hyperoxia.
doi:10.1371/journal.pone.0038839.g005
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Figure 6. Changes in BAL TNFa and IL1ß concentrations. The BAL contents of TNFa (A) and IL1ß (B) were determined by ELISA were also
segregated according to the molecular size of HA. Data are presented as box and whisker plots of 25th and 75th percentiles showing outliers as
additional dots. Both inflammatory markers were significantly higher in the animals that had LMW HA in the lung. Newborn pigs resuscitated with
100% O2 and treated with NAC had significantly lower TNFa (C) and IL1ß (D) than those without NAC treatment, suggesting that antioxidant
treatment decreases the inflammatory response to resuscitation with hyperoxia.
doi:10.1371/journal.pone.0038839.g006
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Quantitative RT-PCR
Total RNA was extracted from lung tissues using RNeasy Plus
Mini Kit (QIAGEN Inc., Valencia, CA, USA), following the
manufacturer’s instructions. Extracted RNA concentration of each
sample was quantified using a NanoDrop ND-1000 Spectropho-
tometer (Thermo Fisher Scientific, Wilmington, DE, USA).
Reverse transcription was performed with 1 mg of total RNA in
a 20 ml volume using iScript cDNA synthesis kit (BIO-RAD Inc.,
Hercules, CA, USA). The real time quantitative PCR were
Figure 7. Fragmentation of HA by peroxynitrite and stimulation of TNFa and IL1ß by oligomeric HA in vitro. HMW HA (HealonTM,
16106 Da, Lane 2) was exposed to 100 mM 3-morpholinosydnonimine (SIN-1), a compound that spontaneously releases NO and superoxide to
generate peroxynitrite. Exposure of HMW HA to SIN-1 results in degradation to LMW HA (300–500 kDa, Lane 6). Exposure to SIN-1 in the presence of
600 mU/ml superoxide dismutase (SOD) partially protects this degradation (Lane 7). Exposure to 300 mM PAPANOATE, a pure NO donor, does not
degrade HealonTM (Lane 8). In addition, treatment of HealonTM with either 1 U/ml Streptomyces hyaluronidase at 60uC for 2 hours (Lane 4) or
sonication for 2 minutes (Lane 5) results in formation of LMW HA. Just heating HMW HA at 60uC in the absence of hyaluronidase did not degrade HA
in the same manner as in the presence of enzyme (Lane 2). Lane 1 has 200 kDa HA (ICN) and Lane 9 contains Hind III digested DNA makers.
doi:10.1371/journal.pone.0038839.g007
Figure 8. Stimulation of TNFa and IL1ß production by a 6mer HA oligosaccharide. RAW264.7 murine macrophages (16106) were
stimulated with a 10 mg/ml of 6-mer HA oligosaccharide in vitro. Supernatant IL1ß and TNFa were measured using standard ELISA. HA6 significantly
stimulated the expression of both IL1ß and TNFa in the macrophage cell line, thereby confirming that LMW HA can stimulate the expression of
inflammatory cytokines in macrophages.
doi:10.1371/journal.pone.0038839.g008
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performed on a 7900 HT fast real-time PCR system (Applied
Biosystems, Foster, CA, USA) using 2 ml cDNA, 7 ml diethylpyr-
ocarbonate water, 10 ml SsoFastTM Probes Supermix (BIO-RAD
Inc., Hercules, CA, USA) and 1 ml primer of TaqMan Gene
Expression Assay. Forty cycles of amplification were performed.
Cycle threshold (Ct) values were determined using SDS 2.3
software. The gene of interest was normalized to the Ct value of
the endogenous reference gene, 18s rRNA, using the DCt method
described by Pfaffl [81]. The primer/probe sequences are listed in
Table 4.
Myeloperoxidase and N-acetylglucosaminidase Activities
Myeloperoxidase (MPO) and N-acetyl-ß-glucosaminiadase
(NAG) activities served as markers of lung neutrophil and
macrophage contents respectively, and were determined as
previously described [82]. Lung tissue was weighed for normal-
ization of data. For MPO activity, 25 ml of sonicated samples or
4.15 - 83 mU of MPO standards (Sigma, St. Louis, MO) were
loaded in 96-well plates. Sixty microliters 0.1M K2PO4, 20 ml
0.5% H2O2, and 20 ml 1.25 mg/ml O-diansidine (ICN Biomed-
icals, Irvine, CA) were added to each well. After incubation at
room temperature for 15 minutes, the reaction was stopped by the
addition of 20 ml 1% sodium azide. The change in absorbance at
450 nm over the 15 minutes provides an index of MPO activity
and correlates with neutrophil content. For NAG activity, 20 ml of
sonicated sample or 25–400 mU of ß-N-acetylglucosaminidase A
standard (Sigma, St. Louis, MO) was loaded in 96-well plates. Ten
microliters 0.1% Triton X and 20 ml 15 mM p-nitrophenyl N-
acetyl-b-D-glucosaminide (Sigma, St. Louis, MO) were added to
each well. After incubation at 37uC for 30 minutes, 200 ml 0.2 M
sodium carbonate was added to each well to stop the reaction. The
change in absorbance at 405 nm was measured as an index of
NAG activity and correlates with macrophage content.
ELISA for TNFa and IL1ß
Serum TNFa and IL1ß concentrations were determined using
commercially available ELISA kits (R&D Systems) as per
manufacturer’s instructions.
In vitro Analysis of HA Fragmentation by Peroxynitrite
In order to confirm superoxide and peroxynitrite fragmentation
of HA, we exposed HealonTM, a clinical grade HMW HA
product, to various conditions and then examined HA size using
gel electrophoresis and staining with StainsAll. HMW HA
(HealonTM, 16106 Da) was exposed to 100 mM 3-morpholino-
sydnonimine (SIN-1), a compound that spontaneously decomposes
at pH 7.4 to release NO and superoxide, thereby generating
peroxynitrite. HA was also exposed to SIN-1 in the presence of
superoxide dismutase (600 U/ml) to decrease superoxide and
peroxynitrite. Exposure to PAPANOATE (300 mM), a pure NO
donor that does not generate either superoxide or peroxynitrite
was used as a control. In addition, HealonTM was treated with
either Streptomyces hyaluronidase (1 U/ml) at 60uC for 2 hours or
sonication for 2 minutes, methods known to fragment HA. In
addition to Hyalose HMW and LMW HA markers, HealonTM
was used as a marker of HMW HA and HA of molecular size
200 kDa (ICN) was used as a marker for LMW HA.
HA Oligosaccharide Stimulation of RAW264.7 Cells
The murine macrophage cell line RAW264.7 was stimulated by
various concentrations of HA6, a six sugar oligosaccharide
obtained from Seikagaku Corporation (Tokyo, Japan), which
was shown to be free of endotoxin, protein and nucleic acid. Cells
(16106) were exposed to 10 mg/ml HA6 for 24 hours. The
supernatant was spun to clear cells and stored at 280uC for TNFa
determination. The cells were harvested and IL1ß concentrations
determined in equal amounts of protein lysate.
Statistical Analysis
At least 7 animals were included in each group. All animal
physiology data are presented as mean 6 SD. For in vitro studies,
experiments were repeated at least three times and representative
Figure 9. Overall model of the role of oxidative and nitrative
stresses and LMW HA in asphyxia and hyperoxia-stimulated
inflammation. Exposure to 100% oxygen in asphyxiated newborn
pigs results in the production of superoxide and peroxynitrite that
cause the fragmentation of HMW to LMW HA. LMW HA, in turn
stimulates inflammatory cytokine expression in macrophages and
promotes inflammation. Strategies to prevent the formation of LMW
HA, such as limiting oxygen exposure or treatment with antioxidants
(the current work) will result in decreased inflammation. This model
predicts that direct blockade of LMW HA should also achieve the same
result.
doi:10.1371/journal.pone.0038839.g009
Table 4. Quantitative real time RT-PCR primers.
Gene of Interest Forward Primer Reverse Primer
18s GAGAAACGGC TACCACATCC GGACACTCAG CTAAGAGCATCG
IL1ß AAGGCTCTCCACCTCCTCA TTGATCCCTAAGGTCACAGGTATCT
TNFa CCTACTGCACTTCGAGGTTATCG GGCCAGAGGGTTGA
has1 CTCGGCGACTCGGTGGACTAC GGGGACCACTGATGCAGGACA
has2 AGCAGCCCATTGAACCAGGGACTTG AGGGTCGGTGGCGGGCAGTTTCCAAAAC
has3 CCTACTTTGGCTGTGTGAAA AGGCTGGACATATAGAGAAG
hyal1 CAGTGCCCTAGGTGGACC CACCCGATCCTTGAGTGAG
hyal2 CGGTATAGGTCTCCCAGTTCTG CAGGCGCAGTATGAATTTGAG
Forward and reverse primers used for quantitative real time RT-PCR.
doi:10.1371/journal.pone.0038839.t004
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data are shown. Results are presented as mean 6 SEM. Percent
control data were calculated by using the mean of all control
animals. Differences among groups were analyzed using one-way
Analysis of Variance (ANOVA). When statistically significant
differences were found (p,0.05), individual comparisons were
made using the Bonferroni/Dunn tests.
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Abstract 
The association between gene expression at birth of 11 candidate genes with 
important innate and adaptive immune functions and later RSV disease was 
investigated. Cord blood was collected from 2108 newborns. 47 were subsequently 
RSV positive. Gene expression analysis by RT-qPCR was compared to 17 controls. 
There was downregulation of IL7R (p=0.0001) and CCR7 (p=0.002), and in the 
severe disease subcategory, downregulation of TLR4 (p=0.003). IL7R and CCR7 
facilitate communication between adaptive and innate immune systems. TLR4 
activates the innate immune system on RSV exposure. Delayed innate and adaptive 
immune activation may predispose children to more severe RSV disease. 
Key Words: 
Respiratory Syncytial Virus; IL7; IL7R; TLR4; CCR7; Children; Gene expression; 
Immunity; Dendritic cells; Lymphocytes
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Background 
Respiratory syncytial virus (RSV) causes yearly epidemics of bronchiolitis and viral 
pneumonia in the pediatric population. About 2/3 of all children are exposed the first 
year of life, and almost all by the age of 2 years [1]. Most have mild upper airways 
disease. 22 - 31/1000 require hospital admission [1, 2], but have usually had a normal 
gestation and birth, and have otherwise appeared healthy. Why so few exposed to 
RSV require hospital admission is a focus of on-going research. 
Cellular responses to RSV are summarized in several reviews [3, 4]. Pulmonary 
dendrocytes are key innate immune cells of the respiratory epithelium that recognize 
RSV via Toll-like receptor 4 (TLR4). Dendrocytes then recruit granulocytes and 
monocytes, and migrate to regional lymph nodes, where they present RSV-antigen to 
lymphocytes, mobilizing the adaptive immune system. 
In this study, we hypothesize that differential regulation at birth of ligands and 
receptors involved in the immune response to RSV predisposes to later RSV disease, 
including proteins involved in the regulation of lung pathology by hyaluronan, 
chemoattraction and chemotaxis of myeloid and lymphoid cells, interactions between 
cells of innate and adaptive immune systems, and regulation of lymphocyte responses.  
Methods 
The Akershus Birth Cohort is described in our previous papers [5, 6]. From 3500 
births, we collected 2108 cord blood samples into PAXgene collection tubes 
(PreAnalytiX GmbH, Hombrechtikon, ͒Switzerland) and EDTA tubes. 
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We cross-referenced the microbiology database with the birth cohort to identify 
participants who later had a positive RSV test. Patients were included if RSV positive 
before 36 months of age. 17 Individuals not tested for RSV were randomly selected 
from the cohort as controls. 
Exclusion criteria: 
Cases and controls were assessed for the following exclusion criteria September 2009, 
at age 5 – 6 years: i) conditions known to predispose to severe RSV disease: 
congenital heart disease, gestational age at birth < 34 weeks; chronic airways diseases 
(eg: bronchopulmonary dysplasia, asthma, recurrent lower airways infections 
congenital airways anomalies), or Down’s syndrome. ii) Conditions affecting gene 
regulation at birth: small for gestational age, perinatal infection, metabolic or 
neurological disease. iii) Controls who had moved from our hospital population area, 
or who were admitted to hospital with other respiratory disease. 
Disease categorization: 
Medical records were assessed retrospectively. Criteria for severe RSV disease were: 
mechanical respiratory support; apnea related to respiratory exhaustion; 
supplementary oxygen requirement; intravenous or nasogastric fluid; a significant 
level of respiratory distress, as documented by the pediatrician. Criteria for mild RSV 
disease were: tested for RSV by their GP, but not sent to hospital for admission; sent 
home from hospital without admission; only upper airways disease; mild or no 
respiratory distress, as assessed by the pediatrician.  
RT-qPCR analysis: 
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Total RNA was isolated from cord blood samples and prepared as described in our 
previous paper [5]. Gene expression was quantified by RT-qPCR of mRNA for 
IL7RA, CCR7, CXCL7, TLR4, IL4, IFNG, CCL3, CXCL11, CXCR3, CD44 and 
RHAMM. Please see the supplementary material for a detailed description of the RT-
qPCR analysis. 
Protein analysis: 
Genes significantly regulated in the RT-qPCR were selected for protein analysis. 
Because these genes encode cell membrane-bound proteins, EDTA samples were 
analyzed. 10 samples from each group (control, mild, and severe disease), 
representative of the interquartile range for mRNA expression for each target protein, 
were analyzed. Protein extraction and Western blot analysis was carried out as 
described previously [5]. 
In 2003, cell-layer separation resulted in contamination with erythrocytes and plasma 
in our leukocyte samples. To correct for this, target proteins were normalized against 
the leukocyte-specific surface protein CD45 in our samples [7]. To verify leukocyte 
specificity, new cord blood samples were collected in 2011, and leukocyte, 
erythrocyte and plasma layers carefully separated and analyzed by Western blotting. 
Please see the supplementary material for a detailed description of the protein 
analysis. 
Statistical analysis: 
RT-qPCR data was assessed for normal distribution using the Kolmogorov-Smirnova 
and Shapiro-Wilk tests. Normally and non-normally distributed data were analyzed 
using Student’s T-test and the Mann-Whitney test, respectively. The difference in 
medians was calculated using the Hodges–Lehmann estimator. Differences in mean or 
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median were ILUVWFDOFXODWHGIRUǻǻ&WYDOXHVDQGWKHQFRQYHUWHGWRUHODWLYH
quantities. Subgroup analysis for severity of disease utilized one-way ANOVA or the 
Kruskal-Wallis test. For each sample, target protein to CD45 ratio was calculated, log 
transformed and analyzed using Student’s T-test. A power analysis of previous results 
indicated a need for 11 individuals in each group for a power of 80% in the mRNA 
analysis. We included 17 in the control group. Statistical analyses were carried out 
using Prism 5 (GraphPad Software inc), SPSS 19 and Minitab 15.0 statistical 
software. Using Bonferroni’s correction, p < 0.0045 was considered significant. 
Ethical issues: Regional Ethics Committee approval was obtained before data 
collection began. A guardian gave informed, written consent before study inclusion. 
Results: 
Of 2108 children, 70 were RSV positive before age 3 years; 3 had asthma, 1 had 
repeated pneumonia, 1 had cleft palate and 1 had Down’s syndrome. 64 were eligible 
for inclusion; 47 had sufficient RNA for analysis. The mean age on positive RSV 
testing was 7.7 months (SD 9.4 months); median age 3 months (IQR 2 – 8 months); 
37 were aged < 12 months, and 10 aged 12 months to 35 months. 25 had severe, and 
22 mild disease. Birth, clinical and intervention data are presented in table 1. 8 RSV 
positive patients were not referred to hospital and were therefore classified with mild 
disease. 
Gene Expression: When considering all children with confirmed RSV infection, there 
was a significant downregulation of both IL7R (relative expression 69%; 95% CI 58 – 
83%; p = 0.0001) and CCR7 (relative expression 78%; 95% CI 67 – 91%; p = 0.002) 
in the RT-qPCR analysis. (Figure 1A). 
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On subgroup analysis for disease severity (figure 1B), IL7R and CCR7 had a 
significant one-way ANOVA (p = 0.0006 and p=0.004, respectively) and TLR4 
tended to significance (p=0.02). Post-hoc analysis revealed significant downregulation 
of TLR4 amongst children with severe RSV disease, compared to controls (relative 
expression 64%; 95% CI 48 – 85%; p = 0.003). 
Protein analysis: Western blot analysis to verify CD45 specificity is presented in the 
supplementary material (figure S1). We can correct for erythrocyte, but not plasma 
contamination, due to non-specific anti-CD45 antibody binding to plasma proteins. 
Plasma contamination is likely to be evenly distributed between groups, reducing 
leukocyte-protein concentration, but not the ratio of means. However, intra-group 
variation is likely, reducing statistical power.  
IL7R, CCR7 and TLR4 were selected for protein analysis. Figure 1C presents CD45 
ratios for controls and cases. There were no significant associations but there are 
obvious trends that support our mRNA findings. 
Discussion: 
In this nested case-control study, we find downregulation of IL7R and CCR7 at birth 
in the cord blood of children who are later RSV positive. There was significant 
downregulation of TLR4 in patients later admitted with severe disease. For several 
genes a large variance meant a lack of power to detect clinically interesting 
differences. This was particularly relevant for CXCR3; IFNG; IL4; RHAMM and 
CXCL11. 
Whilst protein results do not statistically confirm our mRNA findings, the trends do 
support them. The Western blot experiment may have lacked power to detect 
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significant differences. We cannot exclude altered protein expression due to 
posttranscriptional regulation of mRNA by microRNA or other mechanisms. 
Control individuals were probably exposed to RSV. We have no information about 
their clinical symptoms other than that they did not present to pediatric units in our 
region, and that their GP did not send a nasopharyngeal aspirate for RSV detection. 
Given our knowledge of our catchment population, public expectations of Norwegian 
health services, and the tendency for GPs in our area to refer younger children for 
assessment by a pediatrician, we believe it probable that control individuals had a 
mild course of RSV disease such as rhinitis, and that the chance of severe RSV 
disease in the control group was low. However, we cannot exclude overlap between 
mild and control groups. Disease severity subgroup allocation may be confounded by 
retrospective collection of clinical data, leading to erroneous classification. This will 
not have affected the results for IL7R or CCR7, where mild and severe groups were 
similar, but may affect results for TLR4. 
IL7RA is in peripheral blood expressed by mature T-lymphocytes, closely 
determining cellular responses to interleukin-7 (IL7). IL7 signaling is an important 
regulator of T-cell survival and homeostasis, preventing apoptosis, promoting T-cell 
proliferation in some conditions, maintaining peripheral T-lymphocyte levels during 
immune responses, and possibly regulating effects of T-cell receptor stimulation. IL7 
and IL7RA deficient mice have depleted thymocyte and T-lymphocyte levels [8].  
CCR7 regulates dendrocyte and lymphocyte migration, both to and within lymph 
nodes. This migration is essential for communication between innate and adaptive 
immune systems. CCR7 is therefore required for the efficient induction and regulation 
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of adaptive immune responses. CCR7 is also involved in the development of antigen 
tolerance [9]. 
TLR4 is a pathogen recognition receptor of the innate immune system, expressed on 
pulmonary epithelial cells, and in abundance on pulmonary dendrocytes. TLR4 single 
nucleotide polymorphisms increase the risk of RSV disease [10]. Binding of RSV 
antigen to TLR4 initiates innate immune responses involving NF-ț%PHGLDWHG
production of signaling and anti-viral factors; dendrocyte activation; granulocyte, 
macrophage and NK-cell recruitment; and dendrocyte migration to lymph nodes, 
where they initiate the adaptive immune response [4, 11]. TLR4 is also a low 
molecular weight hyaluronan receptor [12]. CD44 mediates immune responses 
initiated by hyaluronan/ TLR4 interactions [13], but its expression was not associated 
with predisposal to RSV infection. 
IL7RA and CCR7 are not previously associated with RSV, but mice deficient in these 
proteins have a severe combined immunodeficiency phenotype [8, 9]. The clinical 
relevance of gene expression levels seen in this study is unknown. The children in our 
study did not have life-threatening disease, chronic disorders or repeat infections. The 
immune phenotype predisposing to RSV disease that is suggested by this study is 
therefore not likely to lead to severe immunodeficiency. 
Cohort samples were taken after a stressful experience (birth), evoking an immune 
response, and we can therefore make conclusions on the immune response of these 
neonates. We previously reported downregulation of TNF receptor 25, Dicer and the 
NF-ț%V\VWHPLQWKLVFRKRUW[5, 6]. In light of these and current findings, it seems 
reasonable to speculate that in children who develop RSV disease, immunological 
differences present at birth may involve initiation of the innate immune response, 
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communication between innate and adaptive immune systems, and homeostasis of 
peripheral T-lymphocytes. A unifying cause explaining all of our findings might be 
genetic or epigenetic variations in one or more of the genes we have described. Inter-
group variation in the differential leukocyte count could also explain our findings, 
particularly for IL7R, which is likely expressed by lymphocytes, and TLR4, which is 
likely expressed by myeloid lineages. Unfortunately we did not perform such a count 
in our cohort. A recent study has described no differences in innate immune cell count 
at 1 month of age between infants with and infants without later RSV infection [14].  
El Saleeby et al described a greater risk of severe disease in children with higher RSV 
nasal viral loads and delayed viral clearance [15]. Our findings may explain this 
association: an impaired immune response due to reduced activation of the innate 
immune response, and delayed communication between innate and adaptive immune 
systems could allow for greater viral replication, more extensive epithelial cell 
infection and a greater risk of pulmonary dissemination early during the course of 
infection, ultimately leading to greater RSV-mediated cell death, and therefore a more 
severe immune response when cells of the innate and adaptive immune systems have 
been adequately recruited. 
Conclusion: 
We find downregulation of IL7R and CCR7 in the cord blood of children later testing 
positive for respiratory syncytial virus. In addition, those with severe disease had 
significant downregulation of TLR4. Downregulation of these leukocyte cell surface 
receptors may cause an impaired immune response to RSV, allowing greater viral 
replication and tissue damage, and thus more severe disease. 
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Figure 1: Gene expression at birth in the cord blood of children who later test 
positive for RSV. 
Note: Bars in panel A and B represent either ¸the difference in the means, or  †the 
Hodges-Lehman estimator for the difference between the medians of the control 
group and patient group for each gene, with 95% CI. Panel A: Gene regulation for 47 
children with positive RSV tests compared to 17 controls. The dotted line represents 
the control group median or mean. There is significant downregulation of IL7R and 
CCR7. Panel B: Disease severity subgroup analysis. There is a significant ANOVA 
for IL7R and CCR7, and a tendency to significance for TLR4. Post-testing showed a 
significantly different control group compared to disease groups for IL7R and CCR7, 
indicating that downregulation of these genes predisposes to RSV disease, but does 
not affect the severity of disease. For TLR4, the severe disease group is significantly 
different from the control group *p = 0.003¸, indicating that downregulation of TLR4 
is associated with severe RSV disease, but not mild disease. Panel C: Log ratios of 
target protein to CD45 in Western blots of white blood cells isolated from cord blood. 
Data is expressed as mean (95% CI). There are no significant differences between 
control and RSV disease groups. 
¸Student’s T-test; †Mann-Whitney test; #One-way ANOVA. 
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